Characterization of the risk of palytoxin and analogues as seafood contaminants by Del Favero, Giorgia
  
UNIVERSITÀ DEGLI STUDI DI TRIESTE 
 
XXIV CICLO DEL DOTTORATO DI RICERCA IN  
SCIENZE E TECNOLOGIE CHIMICHE E FARMACEUTICHE 
 
 
CHARACTERIZATION OF THE RISK 
 OF PALYTOXIN AND ANALOGUES  
AS SEAFOOD CONTAMINANTS 
 
Settore scientifico-disciplinare: BIO/15 
 
         DOTTORANDA: Giorgia Del Favero 
 
                                            DIRETTORE DELLA SCUOLA: Prof. Enzo Alessio 
                                             RELATORE:  Prof. ssa Aurelia Tubaro 
                                             CORRELATORE: Prof. ssa Paola Lorenzon 
 
 
ANNO ACCADEMICO 2010/2011 
 
1 
 
INDEX 
                                                                                          Pages 
ABSTRACT/RIASSUNTO…………………………………….. 5 
    
1. INTRODUCTION………………………………….... 11 
    
1.1. Hazard identification…………………………………. 12 
1.1.1. Chemical structure and properties……………………. 12 
1.1.2. Palytoxin and analogues……………………………… 14 
1.1.3. Producing organisms…………………………………. 17 
1.1.4. Molecular target and mechanism of action…………... 23 
    
1.2. Exposure assessment…………………………………. 29 
1.2.1. Distribution of PLTX in marine organisms and 
entrance into the food chain………………………….. 
     
29 
1.2.2. Epidemiological data…………………………………. 31 
1.2.2.1. Oral exposure……………………………………….... 32 
1.2.2.2. Inhalational exposure……………………………….... 35 
1.2.2.3. Dermal exposure……………………………………... 37 
1.2.2.4. Ocular exposure…………………………………….... 39 
    
1.3. Toxicity assessment………………………………….. 40 
1.3.1. In vitro studies………………………………………... 40 
2 
 
1.3.1.1. Effects on excitable cells and tissues……………….... 40 
1.3.1.2. Effects on non-excitable cells and tissues…………..... 44 
1.3.2. In vivo studies……………………………………….... 45 
    
2. AIM OF THE PROJECT…………………………….. 49 
    
3. MATERIALS AND METHODS…………………….. 52 
    
3.1. Materials……………………………………………… 53 
3.1.1. Toxins………………………………………………… 53 
3.1.2. Animals………………………………………………. 54 
3.1.3. Reagents……………………………………………… 55 
    
3.2. Methods………………………………………………. 56 
3.2.1. In vitro studies……………………………………….. 56 
3.2.1.1. Primary culture of skeletal muscle cells……………... 56 
3.2.1.2. Sulforhodamine-B assay……………………………... 57 
3.2.1.3. May-Grunwald Giemsa stain………………………… 57 
3.2.1.4. Atomic Force Microscopy…………………………… 57 
3.2.1.5. Videoimaging………………………………………… 58 
3.2.1.6. Immunocytochemistry……………………………….. 60 
3.2.1.7. Binding experiments…………………………………. 60 
3 
 
3.2.1.8. Statistical analysis……………………………………. 61 
3.2.2. In vivo studies………………………………………… 61 
3.2.2.1. Experimental design………………………………….. 61 
3.2.2.2. Recovery……………………………………………... 62 
3.2.2.3. Light microscopy…………………………………….. 62 
    
4. RESULTS……………………………………………. 63 
    
4.1. In vitro studies………………………………………... 64 
4.1.1. Toxicity of PLTXs on differentiated skeletal muscle 
cells…………………………………………………... 
     
64 
4.1.2. Effects of PLTXs on the cell morphology…………… 67 
4.1.3. Effect of PLTXs on cell response to Acetylcholine….. 70 
4.1.4. [Ca
2+
]i increase induced by PLTXs…………………... 73 
4.1.5. Contribution of extracellular Na
+
 and Ca
2+
 in the   
mechanism of action of PLTXs……………………… 
    
75 
4.1.6. Influence of Ca
2+
 on PLTX binding………………….. 83 
4.1.7. Contribution of Ca
2+
 stores to the [Ca
2+
]i increase and 
cytotoxicity induced by PLTX……………………….. 
    
86 
4.1.8. Contribution of Ca
2+
 influx to the [Ca
2+
]i increase and 
cytotoxicity triggered by PLTX……………………… 
    
88 
4.1.9. Extracellular Ca
2+
 influx through voltage-dependent 
channels and Na
+
/Ca
2+
 exchanger……………………. 
    
90 
4.1.10. Extracellular Ca
2+
 influx through voltage-independent  
4 
 
Ca
2+
 channels and its contribution to the cytotoxicity.. 94 
4.1.11. Contribution of Cl
-
 to  the PLTX-induced toxicity…... 100 
4.1.12. Structure activity relationship: PLTX-analogue  
OST-D………………………………………………... 
 
104 
    
4.2. In vivo studies………………………………………… 107 
4.2.1. Lethality……………………………………………… 107 
4.2.2. Symptoms…………………………………………….. 108 
4.2.3. Body weight………………………………………….. 109 
4.2.4. Necroscopic examination…………………………….. 110 
4.2.5. Recovery……………………………………………... 111 
4.2.6. Histological analysis…………………………………. 112 
    
5. DISCUSSION………………………………………... 126 
    
5.1 In vitro studies………………………………………... 127 
5.2. In vivo studies………………………………………… 136 
    
6. CONCLUSIONS……………………………………... 145 
7. REFERENCES……………………………………….. 148 
    
 
 
5 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABSTRACT 
RIASSUNTO 
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Characterization of the risk of Palytoxin and analogues 
as seafood contaminants 
 
The present thesis was developed for the characterization of the risk 
associated to palytoxins as seafood contaminants. To this aim, an 
integrated approach between in vitro and in vivo studies was chosen. 
Palytoxin and its analogues are known seafood contaminants that can 
accumulate in several edible species of shellfish, fish, crustaceans and 
echinoderms. Generally, primary symptoms associated to the ingestion 
of contaminated food involve the gastro-intestinal apparatus and later 
develop with the involvement of the muscular tissue. For a better 
comprehension of the mechanism of action of this family of biotoxins, 
the effects of PLTX have been studied on primary culture of mouse 
skeletal muscle cells. The myotoxic insult triggered by PLTX was 
described in detail with the definition of the cytotoxicity together with 
the description of the morphologic alterations and functional 
impairment caused by the toxin. Moreover, the influence of the ionic 
composition of the extracellular medium on the effects of the toxin was 
elucidated. Primary cultures of skeletal muscle cells, that presents in 
vitro many of the peculiarities of the adult muscle fiber, allowed the 
investigation of the membrane mechanisms that regulate the 
intracellular calcium increase triggered by the toxin. It was possible to 
discriminate the difference between calcium release from intracellular 
stores and the calcium entrance from extracellular compartment both 
elicited by the toxin, and to understand the importance of the latter in 
relation to the toxic event. Moreover, the involvement of the main 
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membrane channels and transporters that may be related to the entrance 
of calcium was investigated and the crucial role of stretch-activated 
channels in the mechanism of toxicity was demonstrated. Once defined 
the crucial molecular mechanisms of action of PLTX, experiments 
were also performed with two of its analogue: the 42-hydroxyl-
palytoxin and the ostreocin-D.  
In parallel to in vitro studies, the effects of repeated oral administration 
of PLTX in mice were also investigated. In fact, in vitro studies are not 
sufficient for the complete comprehension of the real hazard associated 
to a food contaminant, since molecules once in contact with the body 
may undergo adsorption, distribution and metabolism before reaching 
the target tissue. Short-term (7 days) administration of the toxin 
revealed toxicity at all the doses tested and lethality was recorded in the 
treated animals already from the dose of 30 µg/kg. Histological 
analysis highlighted alterations in several tissues: severe inflammatory 
processes and even foci of necrosis were observed in lungs. Alteration 
of the muscular tissues was visible as fiber separation and degeneration 
in the heart and increased cellularity between fibers in skeletal muscle. 
Moreover, depletion of glycogen content of hepatocytes and moderate 
alterations of the spleen were also observed. Data collected in the 
present project revealed, for the first time, toxicity of PLTX at doses 
much lower than that currently used by European Food Safety 
Authority (EFSA) for the estimation of limit values for presence of 
these compounds in seafood. For this reason, these results are likely to 
have a considerable impact at regulatory level and to have crucial 
importance for the protection of the consumers. 
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Caratterizzazione del rischio da palitossina e composti analoghi 
quali contaminati dei prodotti ittici destinati ad uso alimentare 
 
Il presente lavoro di tesi è stato sviluppato con lo scopo di 
caratterizzare il rischio associato alla presenza delle palitossine quali 
contaminanti dei prodotti ittici destinati ad uso alimentare. A tal fine,  
è stato scelto un approccio integrato tra studi in vitro e in vivo. La 
palitossina e i suoi analoghi sono noti contaminanti dei prodotti ittici e 
possono accumularsi in diverse specie edibili di molluschi, pesci, 
crostacei ed echinodermi. Generalmente, i primi sintomi associati 
all’ingestione di cibo contaminato coinvolgono l’apparato gastro-
intestinale e poi si sviluppano con l’interessamento del tessuto 
muscolare. Per una migliore comprensione del meccanismo d’azione di 
questa famiglia di biotossine, gli effetti della PLTX sono stati studiati 
mediante colture primarie murine di cellule muscolari scheletriche. 
L’insulto miotossico indotto dalla PLTX è stato descritto nel dettaglio 
con la definizione della citotossicità assieme alla descrizione delle 
modifiche morfologiche e delle alterazioni funzionali causate dalla 
tossina. Inoltre, è stata caratterizzata l’influenza della composizione 
ionica dell’ambiente extracellulare negli effetti della tossina. Le colture 
primarie di cellule muscolari scheletriche, che presentano molte delle 
caratteristiche peculiari della fibra muscolare adulta, hanno permesso 
l’indagine dei meccanismi che regolano l’aumento intracellulare di 
calcio indotto dalla tossina. E’ stato possibile discriminare la 
differenza tra il rilascio di calcio dai depositi intracellulari e l’entrata 
di calcio dai compartimenti extracellulari, entrambi effetti indotti dalla 
tossina, e comprendere l’importanza del secondo meccanismo in 
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relazione agli eventi tossici. E’ stato indagato il coinvolgimento dei 
canali e trasportatori di membrana in relazione all’ingresso di calcio 
ed è stato dimostrato il ruolo cruciale dei canali attivati da stiramento 
nel meccanismo di tossicità. Una volta definiti i meccanismi d’azione 
cruciali per la PLTX, esperimenti sono stati condotti anche con due dei 
suoi analoghi, la 42-idrossi-palitossina e l’ostreocina-D.  
Parallelamente agli studi in vitro, sono stati studiati gli effetti della 
somministrazione orale ripetuta della PLTX nel topo. Infatti, gli studi 
in vitro non sono sufficienti alla comprensione del reale pericolo 
associato ad un contaminate alimentare, dal momento che, le molecole, 
una volta a contatto con l’organismo, possono subire assorbimento, 
distribuzione e metabolismo prima di raggiungere il tessuto bersaglio. 
La somministrazione a breve termine della tossina (7 giorni) ha 
rivelato tossicità a tutte le dosi somministrate, e letalità è stata 
registrata negli animali trattati già alla dose di 30 µg/kg. Le analisi 
istologiche hanno evidenziato alterazioni a carico di diversi tessuti: a 
livello polmonare sono stati osservati severi processi infiammatori 
associati anche a focolai di necrosi. Le alterazioni del tessuto 
muscolare erano visibili come degenerazione e separazione delle fibre 
nel cuore e aumento degli elementi cellulari tra le fibre del muscolo 
scheletrico. Inoltre sono stai osservati, deplezione del contenuto di 
glicogeno negli epatociti e moderate alterazioni della milza. I dati 
raccolti nel presente elaborato hanno rivelato, per la prima volta, la 
tossicità della palitossina a dosi molto inferiori rispetto a quelle 
correntemente utilizzate della European Food Safety Authority (EFSA) 
per la stima di valori limite per la presenza di questi composti nei 
prodotti ittici destinati ad uso alimentare.  Per questo motivo, i  
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risultati avranno probabilmente un considerevole impatto a livello 
legislativo e un’importanza cruciale per la protezione dei consumatori. 
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1. INTRODUCTION 
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Risk characterization is a complex procedure that is aimed at the 
evaluation of the balance between the intrinsic hazard represented by 
the molecule, in our study palytoxin, and the likelihood of exposure, 
thus the probability of a person to come into contact with it. The 
evaluation of the data present in literature will develop in three major 
area: hazard identification, exposure assessment and toxicity 
assessment. 
 
1.1. Hazard identification 
 
Hazard identification is the first step of risk characterization and risk 
assessment; this procedure is aimed at description of the target 
molecule, giving all information necessary for the comprehension of 
the chemical properties, mechanism of action and ultimately to toxicity.  
 
1.1.1. Chemical structure and properties 
 
The molecule that gave origin to the group of biotoxins, nowadays 
called “palytoxins”, was discovered in 1971 from the research group of 
Prof. Moore, in Hawaii (Moore and Scheuer, 1971). Palytoxin was 
isolated from soft-corals of the genus Palythoa and, from the chemical 
point of view, as well as from biological properties, differed from any 
other biotoxin discovered up to that moment. Initially, molecular 
weight was estimated to be 3300 Dalton, but at the beginning of the ’80 
it was finally determined, for PLTX and analogues in a range between 
2659 and 2680 Da, depending on the source of toxin extraction (Moore 
and Bartolini, 1981; Riobò and Franco, 2011). The elucidation of the 
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planar structure of the molecule (Figure 1) was achieved only ten years 
after its discovery, in 1981. The challenge was carried out 
independently by two research groups, nearly simultaneously, at the 
Nagoya University in Japan (Uemura et al., 1981), and in United States 
(Moore and Bartolini, 1981). Later in the decade, chemical studies on 
palytoxin went on, leading initially to the definition of the 
stereochemistry of the 64 chiral centers (Fujioka et al., 1982; Cha et al., 
1982; Shimizu, 1983) and, later, to its complete synthesis (Kishi, 1989).  
Ultra Violet spectrum of PLTX shows bands at 233 nm and 263 nm, 
corresponding to the two chromophores of the toxin; in particular the 
first signal refers to the conjugated double bonds and the other 
describes the group 3-amido-N-(3-hydroxypropil)-acrylamidic. The 
importance of the latter for the toxicity of the molecule was identified 
already during the first characterization of PLTX published in 1971. In 
fact, Moore and Scheuer (1971) demonstrated that to a loss of the 
amidic group corresponded a reduction of biological properties of the 
molecule. 
In accordance with its structure, rich in hydroxyl groups, PLTX is 
soluble in polar solvents such as ethanol, methanol, water and pyridine 
(Moore and Scheuer, 1971). In aqueous solution PLTX was found to 
exist as a dimer with two molecules overlapping each other to give a 
figure “∞” shape. For the formation of the dimer, the presence of a free 
amino group is crucial and any modification in this respect alters toxin 
behavior (Inuzuka et al., 2007). For instance, the acetylation of the 
amino group stabilizes the formation of a monomer in aqueous 
solution, with a peculiar “∩” shape (Uemura, 2006; Inuzuka et al., 
2007). Moreover, the functionalization of the amino group not only 
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makes impossible the formation of the dimer, but seems to reduce 
toxicity of the molecule as well (Hirata et al., 1979; Ohizumi and 
Shibata, 1980; Kudo and Shibata 1980). Thus, the free amino group, 
that accounts for one of the three nitrogen ions present in the molecule, 
seems to be of crucial importance, not only for the physical-chemical 
behavior of the toxin, but also for its biological activity. 
The apparent degradation of the toxin in alkaline or acidic environment 
described by Wiles et al. (1974) has been an insidious matter of 
discussion, especially during the performance of oral toxicity studies. 
Loss of activity after intra-peritoneal (i.p.) administration of toxin pre-
incubated with acids or bases, as described in 1974, should assure a 
similar loss of function also after administration of the molecule in the 
gastro-intestinal tract. In spite of that, this loss or reduction of potency 
was not clearly visible in the studies conducted so far (Sosa et al., 
2009). 
Palytoxin, in addition to the peculiar behavior in aqueous solution, is 
also known for its specific affinity for the plastic surfaces. In particular, 
it was already observed, at the beginning of the ’90s, that biological 
effects i.e. alteration of blood pressure induced by the toxin, were 
highly variable after the passage through a polyethylene plastic tubes 
(Taylor et al., 1991).  
 
1.1.2. Palytoxin and analogues 
 
The discovery of palytoxin was followed by the chemical 
characterization of other molecules similar in structure, that, on the 
whole, finally constituted the so-called “palytoxin group”. The 
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discovery of palytoxin analogues began from the analysis of different 
species of soft corals of the genus of Palythoa. Minor constituents of 
Okinawan Palythoa tubercolosa revealed to be slightly different from 
the parent PLTX and were named homopalytoxin, bishomopalytoxin, 
neopalytoxin and deoxypalytoxin (Uemura et al., 1985). Many years 
later, in 2009, another molecule was chemically characterized from 
samples of Palythoa toxica and was named 42-hydroxyl-palytoxin (42-
OH-PLTX) for the presence of an additional hydroxyl group in position 
42 of the aliphatic backbone (Ciminiello et al., 2009). 
Palytoxin analogues, discovered in samples of corals, were soon 
followed by other molecules, isolated from microalgae of the genus 
Ostreopsis. In this respect, the first molecule identified was Ostreocin-
D (OST-D) from the unicellular benthonic microalgae of Ostreopsis 
siamensis (Usami et al., 1995; Ukena et al., 2001). This result, not only 
widened the number of molecules belonging to the “family” of 
palytoxins, but also led to the comprehension that these molecules are 
part of the so-called “algal toxins”. From the discovery of OST-D, the 
analysis of different species of Ostreopsis revealed many other PLTX-
analogues, distributed all over the world. Mascarenotoxin-A, B and C 
(Lenoir et al., 2004; Rossi et al., 2010) were isolated from O. 
mascarenensis collected in the Indian Ocean and Ostreopsis cf. ovata 
of the Mediterranean Sea. Along the Italian coast the first palytoxin-
like compound isolated was Ovatoxin-A. Ovatoxin-A resulted to be 
very similar to parent palytoxin, with similar fragmentation pattern and 
chromatographic behavior, but slightly different, for the absence 3 of 
hydroxyl groups in position 17, 44, 64 and the presence of the –OH 
group in position 42 of the aliphatic backbone (Ciminiello et al., 2008; 
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Ciminiello et al., 2012a).  This compound resulted to be the major 
product of Ostreopsis ovata collected along the Ligurian coasts during 
the toxic outbreak of 2005-6 (Durando et al., 2007) and also the major 
toxin constituent detected in Ostreopsis cf. ovata that we collected in 
autumn 2009 in the Gulf of Trieste (Honsell et al., 2011).  
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Figure 1.  PLTX and analogues, the chart summarizes the structural differences 
between commercial PLTX, 42-OH-PLTX and OST-D.  
 
Progress of analytical techniques, driven by the growing interest of the 
scientific community around palytoxin and its analogues, allowed the 
identification of the complex toxins profile present in Mediterranean 
Ostreopsis ovata, with the identification of Ovatoxin-B, C, D, E 
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(Ciminiello et al., 2010; Rossi et al., 2010), and Palytoxin-B (Rossi et 
al., 2010) and, will likely be the driving force for the discovery of new 
molecules. 
 
1.1.3. Producing organisms 
 
Palytoxin was originally isolated from zoanthid of the genus Palythoa 
(Moore and Scheuer, 1971). After the discovery of the molecule, 
Palytoxin and analogues were isolated in a wide number of species of 
soft corals, such as Palythoa toxica (Moore and Scheuer, 1971; 
Ciminiello et al., 2009), P. tuberculosa (Kimura and Hashimoto 1973; 
Ishida et al., 1983) and P.aff. margaritae (Oku et al., 2004). Analysis of 
the coral reefs of the Caribbean Sea revealed presence of PLTX-like 
substances also in samples of Palythoa caribaeorum (Attaway and 
Ciereszko, 1974; Béress et al., 1983) and P. mammillosa (Attaway and 
Ciereszko, 1974). The toxin was found also in Palythoa caribaeorum, 
P. mammillosa from Colombian coasts, and in other zoanthid species, 
such as Zoanthus solanderi and Z. sociatus, competitors of Palythoa 
species for space in the reef (Gleibs et al., 1995). To strength the idea 
that other component of the coral reefs may contain PLTX-like 
substances, a compound closely related to reference PLTX has been 
isolated also in sea anemones (phylum Coelenterata), such as the 
Radianthus macrodactylus (Mahnir et al., 1992). Recently, zoanthids 
Anthozoa and Hexacorallia, normally sold in aquarium hobbyist shops 
in United States, were found to contain considerable amounts of 
palytoxin (ranging from 0.5-3.5 mg of crude toxin/g zoanthid). In more 
detail, parent PLTX together with its analogues 42-OH-PLTX and 
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deoxy-palytoxin has been recently isolated in species of P. heliodiscus 
and P. mutuki (Figure 2; Deeds et al., 2011). 
 
 
Figure 2. Zoanthid colony, collected from a home aquarium in 2008, responsible for 
a severe respiratory reaction. Sample was found to contain approx. 600 mg 
palytoxin/g wet zoanthid. Bar represents 1 cm 
(doi:10.1371/journal.pone.0018235.g001 Deeds et al., 2011, modified). 
 
In 1995, the group of Professor Yasumoto isolated and characterized 
PLTX-like compounds from the benthic dinoflagellate of the genus 
Ostreopsis, O. siamensis  (Usami et al., 1995). From that moment, there 
has been a wide consensus in the scientific community in considering 
the unicellular microalgae as the producer of the toxin, even though the 
pathways of biosynthesis of the toxin are still unclear and represent a 
field of open and ongoing research. Beside O. siamensis, PLTX and 
analogues have been isolated from different species of Ostreopsis, such 
as O. ovata (Ciminiello et al., 2008; 2012a), O. mascarenensis (Lenoir 
et al., 2004). Ostreopsis spp. are unicellular epiphytic microalgae, 
classified as benthonic dinoflagellates (Schmidt, 1901; Fukuio, 1981). 
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Originally, they were supposed to colonize tropical and sub-tropical 
areas, but now they are detected more and more frequently also in 
temperate seas, suggesting their increasing and/or wider distribution in 
the benthonic environment, all over the world. In Mediterranean area, 
appearance and proliferations of Ostreopsis cf. ovata (Figure 3 A) and 
O. siamensis (Figure 3 B) were recorded starting from the end of the 
’70s and the ’80s, respectively (Taylor, 1979; Abboud-Abi Saab M., 
1989).  
 
 
Figure 3. Ostreopsis cf. ovata (A) and Ostreopsis cf. siamensis (B) from the 
Tyrrhenian Sea. SEM micrographs (modified from Penna et al., 2005). 
In the Mediterranean area, the specie that prevalently produces PLTX-
like compound is Ostreopsis ovata. Even if Japanese O. siamensis is 
well-known to contain OST-D (Usami et al., 1995; Ukena et al., 2001), 
the same specie does not seem to produce known palytoxins in the 
20 
 
Mediterranean sea. To our knowledge, the only case in which 
Mediterranean O. siamensis was hypothesized to contain PLTX-like 
compound was in 2009, when Cagide and co-workes (Cagide et al., 
2009), described functionally active compounds, that mimicked the 
effects of PLTX, in samples of O. siamensis collected along the 
Andalusia coast, but without chemical confirmation about structure. On 
the other side, the presence of PLTX-like compounds in Ostreopsis 
ovata has been proved with several techniques. Advanced liquid 
chromatography tandem mass spectrometry (LC/MS) has been 
extensively used for the detection of PLTX-like compounds in samples 
of O. ovata (Ciminiello et al., 2011). In addition, LC for the analysis of 
PLTX-like compounds has also been developed with precolumn 
derivatization and fluorescent detection by Riobò and co-workers 
(Riobò et al., 2008a). Recently, our research group has highlighted the 
advantages of the use of anti-PLTX antibodies for the 
immunocytochemical determination of the toxins directly in microalgae 
cells (Honsell et al., 2011). 
Usually, the ideal habitat for the proliferation of Ostreopsis ovata is 
protected, inshore stations (Faust et al., 1996), characterized by low 
hydrodynamism (Vila et al., 2001). During proliferation, microalgae of 
Ostreopsis colonize all surfaces available, including macroalgae 
(Figure 4), rocks, bottom surfaces and also other living organisms 
(Faust et al., 1996; Sansoni et al. 2003; Honsell et al., 2011). This 
aggressive behavior may have severe consequences, and even induce 
mortality, for the organisms commonly populating the benthos, such as 
sea urchins and other echinoderms and coelenterates (Sansoni et al., 
2003). In addition, also shellfish seems to suffer the presence of 
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Ostreopsis, showing decreased adherence to rocky substrates and 
higher mortality rate (Sansoni et al., 2003). 
 
Figure 4. Corallina officinalis covered by cells of O. cf ovata within a mucous web, 
collected in the Gulf of Trieste in 2009 (modified from Honsell et al., 2011). 
 
In Italy, the presence of Ostreopsis spp. was recorded for the first time 
in 1995, along the coasts of Lazio region (Tognetto et al., 1995). From 
that moment, the presence of Ostreopsis spp., with higher prevalence of 
the specie ovata, was recorded along all the peninsula and interested 
both the Tyrrhenian (Sansoni et al., 2003; Zingone et al., 2006; Barone 
2007) and the Adriatic Sea (Gallitelli et al., 2005; Totti et al., 2007), up 
to the northern areas, such as the Gulf of Genoa (Brescianini et al., 
2006; Mangialajo et al., 2008) and the Gulf of Trieste (Monti et al., 
2007; Honsell et al., 2011).  
Comparison of samples of Ostreopsis ovata collected in Tyrrhenian and 
Adriatic Sea revealed morphometric differences, being the Adriatic 
strain nearly twice bigger that the Tyrrhenian, even though they 
appeared genetically uniform. Moreover, comparison of the toxin 
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profile of the two strains, revealed in both cases the presence of 
putative PLTX and Ovatoxin-A (Guerrini et al., 2010).  
The investigation and the comprehension of the algal growth and the 
factors influencing toxin production are obviously matters of crucial 
importance in the comprehension of the toxicity potentially associated 
to proliferations. To this aim, Ostreopsis cells can be harvested and 
cultured in standardized conditions giving precious information for the 
elucidation of the high variability of the sampling “on-field”. Cells 
growth appears tightly regulated and, for every population it is possible 
to distinguish different growth phases. During the exponential phase 
cellular growth rate is maximal, but toxins production seems to be very 
limited. On the contrary, when O. ovata growth stops in the stationary 
stage toxin content in the culture usually increases, in parallel with 
increasing toxicity of growth medium (Guerrini et al., 2010). In spite of 
that, toxin content in algal cells seems to be generally higher than that 
measurable in growth medium (Guerrini et al., 2010; Pezzolesi et al., 
2012).  
Similarly to growth stages, water temperature influences cells 
proliferation and toxin content of Ostreopsis ovata, suggesting slight 
differences between strains of the Tyrrhenian (optimal growth 26-30 °C 
and proliferations usually observed in the middle of the summer; 
Granéli et al., 2011) and the Adriatic Seas (optimal growth 20-22 °C 
and maximum proliferations usually observed between end of August 
and October; Pezzolesi et al., 2012; Monti et al., 2007; Honsell et al., 
2011).  As already observed by Guerrini and co-workers (2010), there 
seems to be a reverse correlation between optimal conditions for toxin 
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production and for cells growth, being the toxin content higher at 25°C 
for the Adriatic Strain of O. ovata (Pezzolesi et al., 2012). 
More recently, the question of PLTX producing organisms came again 
to the forth and some bacterial species were proposed in this respect. 
Zoanthid corals and microalgae are phylogenetically very distant and 
the search of common ancestors, that could explain why they both 
contain similar toxins, led to the hypothesis that bacteria could produce 
PLTXs, or at least some biosynthetic precursors. Evidence to possible 
bacterial origin for PLTX was given already from the discoverer of the 
molecule (Moore, 1982), and in 2000, Frolova and co-workers (Frolova 
et al., 2000) identified, in bacteria, compounds antigenically related to 
PLTX. In 2009 the hypothesis was further explored, and it was 
demonstrated that bacteria isolated from Palythoa caribaeorum exert 
PLTX-like hemolytic activity (Seemann et al., 2009). Moreover, more 
recently parent PLTX and its 42-hydroxyl-derivative were  isolated 
from marine Cyanobacterium Trichodesmium (Kerbrat et al., 2011), 
giving more strength to the possibility that bacteria may be involved in 
the biosynthesis of PLTXs 
 
1.1.4. Molecular target and mechanism of action 
 
The Na
+
\K
+
-ATPase is considered the main molecular target of PLTX 
and its analogues (Habermann 1989; Wu, 2009; Rossini and Bigiani 
2011). The idea that PLTXs may interact with the Na
+
\K
+
 pump  arose 
from many experimental results, that on the whole, led to the definition 
of the molecular target of this family of compounds.  
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Evidence for the definition of the mechanisms of action of PLTX was 
collected even before complete structural elucidation of the molecule. 
The idea that the toxin may interact with cellular structures responsible 
of ionic homeostasis  originated from the simple observation that PLTX 
was able to induce potent muscular contraction (Deguchi et al., 1974; 
Ito et al., 1976; 1977; 1979). In addition, results on mechanical 
properties were soon supported by the measurement of PLTX-induced 
depolarization in muscular tissues (Ito et al., 1976; 1977; 1979) and in 
peripheral (Dubois and Cohen, 1977) and central nervous system 
(Kudo and Shibata, 1980).  
The structural elucidation of the molecule in 1981 (Uemura et al., 1981; 
Moore and Bartolini, 1981) on the one side provided purified working-
material, and on the other, probably gave new stimuli in the definition 
of the mechanism of action of the toxin. The stronger evidence that lead 
to the identification of the Na
+
\K
+
 pump as the molecular target of 
PLTX, came from the observation that the cardiac glycoside ouabain 
was able to inhibit some biological effects of the toxin. Ouabain is a 
potent and known inhibitor of the Na
+
/K
+
 ATPase (Skou, 1957) and 
was found to inhibit PLTX-induced contraction of human umbilical 
artery (Ishida et al., 1981) and, later, to exert its protective effects also 
on non-excitable cells, such as erythrocytes (Habermann and Chhatwal 
1982). PLTX inhibition of the pump was then confirmed on purified 
Na
+
/K
+
 ATPase (Ishida et al., 1983), on mammalian pumps selectively 
expressed in yeast cells (Scheiner-Bobis et al., 1994; Redondo et al., 
1996) and in Na
+
/K
+
 pumps reconstituted in planar lipid bilayers (Kim 
et al., 1995). It is possible that at the beginning, the idea that the Na
+
\K
+
 
pump was the target of palytoxin met some resistances (Wu, 2009) but 
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from that moment, the attention and the efforts of the scientific 
community focused on the interaction between the toxin and the pump 
molecule.  
Even though PLTX and ouabain share the same molecular target, it was 
soon clear that there is a crucial difference between the mechanism of 
action of the two: ouabain blocks the pump in a conformation that 
inhibits ion fluxes, whereas PLTX induces the formation of a pore-
channel in the pump with a conduction around 10 pS (Anner and 
Moosmayer, 1994; Kim et al., 1995; Artigas and Gadsby, 2002). 
Important insights in the comprehension of the ionic fluxes induced by 
the toxin came from experiments performed on ATPases expressed in 
yeast cells: recordings of Na
+
 influx (Redondo et al. 1996) and K
+
 
efflux (Scheiner-Bobis et al. 1994) in this experimental condition ruled 
out the involvement of other cation channels in the primary action of 
PLTX. In physiological conditions, the pump is an active transport 
system that maintains the ionic balance of Na
+
 and K
+
 across the 
plasma membrane. The pump exchanges, against chemical gradient, 
three atoms of Na
+
 and two of K
+
 (Scheiner-Bobis 1996; Horisberger, 
2004), whereas, in presence of PLTX, this ability is completely lost and 
cationic permeability is recordable with a stoichiometry near to 1:1 
(Redondo et al. 1996). To obtain this effect, PLTX seems to disrupt the 
normal alternate gating typical of the pump, promoting the formation of 
a pore within the transporter (Artigas and Gadsby 2003a). After pore 
creation, the newly formed ion translocation pathway shares, at least in 
part, the same transmembrane domains used by Na
+
 and K
+
 during 
physiological binding (Guennoun and Horisberger, 2000; Horisberger 
et al., 2004). Even though PLTX action seems to revert the typical 
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features of the pump, the transporter that interacts with the toxin 
maintains the sensitivity to its physiological ligands, such as K
+
 and 
ATP (Artigas and Gadsby, 2002, 2003b; 2004). On the contrary, the 
ATPase activity per se does not seem to be essential for the action of 
the toxin (Scheiner-Bobis and Schneider, 1997).  
During the normal transport cycle, the pump adopts two major 
conformation: E1 in which binding sites are accessible from the 
cytoplasmic surface and E2, in which access is from the extracellular 
surface, both of them existing as phosphorylated and dephosphorylated 
form (Artigas and Gadsby, 2002).  
The conformation in which the toxin binds to the pump is difficult to 
define; the peculiar effect of PLTX suggests that it may stabilize a 
conformation different from any other physiologically observed, so far. 
In spite of that, PLTX is known to exert its biological effects 
interacting with the cells from the extracellular side (Muramatsu et al., 
1984; Kim et al., 1995). In addition, it was found that the toxin binds 
with highest affinity to phosphorylated pumps, exposed to K
+
-free, high 
Na
+
 external and internal solutions in presence of Mg-ATP. In these 
conditions, it can be expected that the most likely conformation, in the 
steady state could be E2P and for this reason conformation E2P is 
considered the more likely for PLTX binding (Figure 5; Artigas and 
Gadsby, 2004; Horisberger, 2004).  
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Figure 5. Left: different phases of ion transport cycle of Na
+
 pump. Right: proposal of 
interaction between PLTX and pump, with stabilization (rectangle) of ion 
translocation pathway with both gates open (modified from Horisberger, 2004). 
 
On the whole, PLTX interaction with its molecular target transforms 
the pump into a cationic channel-pore, that elicits Na
+
 influx and K
+ 
efflux from the majority of mammalian cells. The consequence of this 
ionic fluxes varies according to the model under investigation and will 
be discussed in detail in the next paragraphs.  
Interaction of PLTXs with molecular targets other than Na
+
/K
+
 
ATPase, is still an on-going debate. As foreseeable, the most 
representative results concerning the research of alternative molecular 
targets involved other members of the P-ATPase family. In fact, this 
family of transporters is characterized by specific sequences highly 
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conserved between types (Horisberger, 2004). Initially, PLTX was 
shown to induce K
+
 efflux, thus one of its typical effects, from yeast 
cells expressing hybrid between gastric H
+
/K
+
 ATPase and Na
+
/K
+
 
ATPase (Farley et al., 2001). Later the effect of the toxin was 
confirmed on H
+
/K
+
 ATPase of rat colon. In this system, PLTX 
induced the formation of a pore that allowed cations to diffuse 
according to electrochemical gradient in a vanadate-sensitive manner 
(Scheiner-Bobis et al., 2002). To confirm the wide range of action of 
PLTXs on P-ATPases, the molecule was found to induce K
+ 
efflux also 
in chimeric enzymes expressing α-subunit of Na+/K+ ATPase and 
catalytic domain of the sarcoplasmic/endoplasmic Ca
2+
-ATPase 
(SERCA; Ito et al., 2003). In addition, studies performed directly on 
microsomal fraction containing SERCA revealed that the toxin 
interacts also with this pump type. In SERCA isolated from cat atrial 
myocytes, it was observed that the toxins slow the Ca
2+
 uptake from the 
pump (Kockskämper et al., 2004). As reported for the Na
+
\K
+
 pump 
(Artigas and Gadsby, 2004; Horisberger, 2004), also in this case the 
toxin seems to interact preferentially with the Ca
2+
-ATPase in 
conformation E2. In spite of this similarity, PLTX blocks the Ca
2+
 
pump without forming a cation channel (Coca et al., 2008). This 
observation, even if relatively low explored, opens interesting insights 
in the comprehension of the mechanisms of action of PLTXs and 
suggests for the toxin a mechanism related with the α-β-oligomeric 
structure of the pump rather than with the primary structure of the 
protein (Coca et al., 2008). 
Although few, data suggesting effects of the toxin without involving of 
the pumps exist. The inhibitory action of PLTX on the transport 
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mechanism of ascorbic acid in cultured bovine adrenal chromaffin cells 
was described (Morita et al., 1996).  
 
1.2. Exposure assessment 
 
1.2.1. Distribution of PLTX in marine organisms and entrance into 
the food chain. 
 
The accumulation of biotoxins into the food chain is a quite common 
and naturally occurring phenomenon (Mebs, 1998). This event may 
lead to the presence of considerable concentrations of toxic compounds 
or metabolites in organisms very different from the producing ones. 
Palytoxin does not make exception and was found in several species of 
crustaceans, fish, mollusks, gastropods and echinoderm, that can 
represent a threat for consumers health (Aligizaki et al., 2011). 
Generally, PLTX-containing marine organism were found both 
proliferating in the coral reef in close contact with the corals (Gleibs et 
al., 1995), or sharing habitat with microalgae of Ostreopsis (Onuma et 
al., 1999; Aligizaki et al., 2008).  
Crustaceans living in the reef of Philippines, such as Demania alcalai, 
Lophozozymus pictor (Yasumoto et al., 1986) and Demania reynaudii 
(Alcala et al., 1988) were found to contain PLTX and PLTX-like 
compounds, quite distributed in all tissues. Similarly, small crustaceans 
(Platypodiella spectabilis) usually living under the crust of Palythoa 
colonies were found to contain PLTX, very similar to that of the 
“housing” colonies. Moreover, predators that eat the zoanthid corals 
were found to contain the toxin as well (Gleibs et al., 1995; Mebs, 
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1998; Gleibs and Mebs, 1999). Polychaete worms (Gleibs and Mebs, 
1999), and fishes (Gleibs and Mebs, 1999; Fukui et al., 1987) were 
found to contain PLTXs in considerable concentrations, but apparently 
without suffering dangerous consequences (Gleibs and Mebs, 1999).  
To mimic the naturally-occurring toxin uptake by filtering mollusks, 
experiments were performed feeding shellfish with Ostreopsis 
siamensis containing PLTX. Shellfish were observed actively feeding 
microalgae for over 84 hours and toxin content and toxicity were 
assessed at the end of the observation period. Analysis of mussels, 
oysters and scallops (hepatopancreas/ muscle and roe) revealed traces 
of toxins prevalently in oysters. Moreover, detectable PLTX-like 
compounds in scallops hepatopancreas were also found (Rhodes et al., 
2002). In addition, to support the idea that shellfish living in close 
contact with Ostreopsis spp may accumulate PLTXs, natural samples 
of shellfish, collected during microalgae proliferation in the Aegean 
sea, were found to be contaminated with PLTX-like compounds 
(Aligizaki et al., 2008). 
In spite of the ability of these toxins to enter the food chain, PLTXs 
may also affect life and development of aquatic organisms 
(Vasconcelos et al., 2010). From the available data, in the 
Mediterranean area, presence of PLTXs-producing organisms seems to 
have more severe impact for marine ecosystem, in comparison to 
tropical environment. As, in some aspect, already described in section 
(Producing organisms), massive proliferation of Ostreopsis ovata has 
been associated with mortality of a broad range of organisms 
populating the benthos (Aligizaki et al., 2011; Sansoni et al., 2003). 
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This sensitivity was confirmed by recent experiments that demonstrated 
how the exposure of crustaceans (Artemia salina, Tigriopus fulvus, and 
Amphibalanus amphitrite) and fish juveniles (D. labrax) to laboratory 
cultured and natural samples of Ostreopsis ovata increases morbidity 
and mortality of this marine vertebrates and invertebrates (Faimali et 
al., 2011). Moreover, it was demonstrated that the PLTXs, not only 
accumulate in shellfish, but may also have toxic effects on them. In 
particular, it was proved that the toxin decreases, in concentration and 
time dependent manner, the metabolic rate of mussels mantle and of 
hepatopancreatic cells. This toxic effect was not observed for other 
toxins, normally accumulating in shellfish, such as okadaic acid 
(Louzao et al., 2010). To strength the idea that PLTX may have 
negative effects on mollusks, it was also demonstrated that the toxin 
induces response of the immune systems of Mytilus galloprovincialis, 
stimulating the phagocytic activity of immunocytes mussels (Malagoli 
et al., 2008). 
 
1.2.2. Epidemiological data 
 
Epidemiological data about the effects for human heath of PLTXs are 
described both in tropical and temperate areas. Primary route of 
exposure, which can be identified in description of PLTX-intoxication, 
are four: ingestion, inhalational, dermal and ocular. Ingestion is 
obviously related to the entrance of the toxin into the food chain, since 
PLTX-producing microalgae and soft corals are not edible species. To 
support the idea that PLTX may enter the food chain, there is its 
widespread presence in several organisms, such as several species of 
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fish, crustaceans and echinoderms. Inhalational exposure, even if not 
confirmed, has been related to the presence of PLTX-like compounds 
in Ostreopsis cells during massive proliferation and to the exposure to 
the steam of boiling water on Palythoa corals. Dermal exposure can be 
related both to the direct contact with PLTX-containing corals, 
especially by aquaria hobbyist, to the contact with Ostreopsis cells in 
seawater or in laboratory. Ocular exposure is very rare, but has been 
described in literature as well (Moshirfar et al., 2010). 
 
1.2.2.1. Oral exposure 
 
The analysis of literature data reveals the presence of discrepancies in 
methodology used for the identification and classification of cases of 
intoxication related to the presence of PLTX in seafood. In particular, 
chemical analysis of food leftover or of human specimens were rarely 
carried out; in many cases the causative agent of the intoxication was 
postulated to be PLTX on the basis of symptoms or type of seafood 
involved. On this basis, cases of human poisoning ascribed to PLTX 
and PLTX-like compounds were classified in a recent review, 
published during the development of this thesis (Tubaro et al., 2011a).  
Cases of intoxication with direct identification of PLTX in the leftovers 
are summarized in table I. In these cases, the presence of PLTXs was 
identified directly in leftovers, with chemical or immunological 
methods. From the analysis of literature data, it was possible to identify 
the main symptoms associated to the ingestion of PLTXs-contaminated 
seafood; intoxication seems usually characterized by initial 
involvement of the gastrointestinal apparatus with nausea, vomiting and 
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diarrhea. After these symptoms, that can be virtually associated to 
every food intoxication, more specific ones usually set on. 
 Table I. Oral exposure. Cases of intoxication with direct identification of the toxin. 
(AST = alanine aminotransferase; CPK = creatine phosphokinase; LDH = lactate 
dehydrogenase;  Tubaro et al., 2011a, modified). 
 
In 1988, Alcala and co-workers described alternating periods of normal 
heart rate and severe bradycardia (30 beats/min), shallow breathing, 
followed by cyanosis around mouth and hands and renal failure. 
Probably, the most distinguishing feature of PLTX intoxication is the 
Location 
year 
Poisoning  
Source 
Cases 
(n°) 
Outcome 
Symptoms and 
clinical data 
Reference 
Philippines 
1984 
Demania 
 Reynaudii 
1 1 death Metallic taste, 
dizziness, 
tiredness, numbness 
of extremities, 
restlessness,  
g.i disturbances. 
bradicardia, 
respiratory probl., 
cyanosis, renal 
failure 
Alcala et al., 
1988 
Japan 
1986 
Scarus  
Ovifrons 
2 1 death Myalgia, dyspnoea, 
convulsions. 
Myoglobinuria, 
high serum levels of 
CPK, AST, LDH 
Noguchi et 
al., 1987 
Madagascar 
1994 
Herklotsichtys 
quadrimaculatus 
1** 1 death Metallic taste of the 
flesh, 
malaise, vomiting, 
diarrhoea 
tingling of the 
extremities, 
delirium 
Onuma et 
al., 1999 
Japan 
2000 
Epinephelus  
bruneus,  
E. fuscogattus 
11 Recovery Myalgia, black 
urine, shoulders 
pain. Serum CPK 
elevation. 
Taniyama et 
al., 2002 
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involvement of the skeletal muscle as one of the main target organs.   
Patients often complain severe myalgia, associated to increased serum 
level of Creatin Phospho Kinase (CPK; Noguchi et al., 1987; Taniyama 
et al., 2002). 
Other cases of intoxication were grouped together because they were 
ascribed to PLTX on the basis of analysis of samples collected or 
purchased after or before the poisoning episode, rather than directly on 
leftovers. In these  cases, seafood was known to potentially contain 
PLTX, but the analysis was not carried out on the samples that caused 
the intoxication. Even if, the correlation with PLTX was not proved, 
the observed symptoms supported the idea that PLTX-like compounds 
may be involved in the intoxication. In particular, predominant 
symptoms impaired the muscular apparatus, with myalgia, even severe 
and muscle spasms (Fusetani et al., 1985; Kodama et al., 1989; Okano 
et al., 1998; Mahmud et al., 2000; Yoshimine et al., 2001). When 
hematoclinical analysis was performed, results generally supported the 
idea that the muscular apparatus was one of the most sensitive target 
organs for this family of toxins. In fact, elevated serum level of CPK 
was accompanied in nearly all cases with myoglobinuria, as a likely 
consequence of rabdomyolysis (Fusetani et al., 1985; Ichida et al., 
1988; Kodama et al., 1989; Tabata et al., 1989; Okano et al., 1998; 
Mahmud et al., 2000; Yoshimine et al., 2001). Among the species 
involved in the cases of intoxication, there were crustaceans of the 
species Demania spp (Alcala and Halstead, 1970) and Lophozozimus 
pictor (Gonzales and Alcala, 1977; Tan and Lee, 1988), well known to 
contain PLTX or PLTX-like compounds (Yasumoto et al., 1986; Lau et 
al. 1995). Fishes mainly involved in the other cases belonged to the 
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specie Tetraodon (Mahmud et al., 2000), which was known to contain 
PLTX-like substances, on the basis of its hemolytic activity inhibited 
by ouabain and anti-PLTX antibodies (Taniyama et al., 2001). 
Moreover, in several other cases Scarus (Ypsiscarus) ovifrons ( 
Fusetani et al., 1985; Ichida et al., 1988; Tabata et al., 1989; Okano et 
al., 1998; Yoshimine et al., 2001) and Decapterus Macrosoma 
(Kodama et al., 1989) were involved. However, for both species, 
analysis was  performed on samples different from those involved 
directly in the intoxication.  
In addition, palytoxin and/or its analogues have been considered 
responsible of a high number of human food-borne poisonings, without 
a confirmatory analysis aimed to toxin identification.  In this group 
were classified all the cases where PLTX was involved only on the 
basis of clinical observations, signs and symptoms (Llewellyn, 2001; 
Shinzato et al., 2008; Arakawa et al., 2010), but the toxin has never 
been found in the specie. 
 
1.2.2.2. Inhalational exposure 
 
Inhalational exposure to PLTX-like compounds has been hypothesized 
in two different case scenarios.  
The first scenario describes symptoms of people that came into contact 
with marine aerosol during massive proliferation of Ostreopsis ovata. 
Even if a direct correlation between the symptoms and the microalgae, 
or PLTXs, has never been found, other algal species are known to 
cause intoxications after inhalational exposure (Fleming et al., 2007). 
Disturbances of the respiratory tract, characterized by severe 
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rhinorrhoea and cough, have been described for the first time along the 
Apulia coast near Bari during an unusual proliferation of microalgae of 
Ostreopsis (Gallitelli et al., 2005). The phenomenon manifested with 
higher intensity in summer 2005 along the Liguria coasts, when 
hundreds of people suffered the so-called “Algal Syndrome” (Durando 
et al., 2007). In this case, people developed symptoms that involved 
respiratory tract, such as sore throat, dyspnoea, rhinorrhoea and cough. 
Moreover, systemic symptoms like fever, nausea and vomiting, in some 
cases associated with mild leucocytosis and neutrophilia, were also 
observed (Table II). Respiratory symptoms and systemic symptoms 
such as fever and/or headache were observed many times during 
Ostreopsis proliferation in all the Mediterranean area: Italian, (Di Turi 
et al., 2003; Sansoni et al., 2003; Gallitelli et al., 2005), Spanish 
(Kermarec et al., 2008 ; Barroso García et al., 2008) and French coasts 
(Kermarec et al., 2008 ; Tichadou et al., 2010) were all involved.  
The second scenario of inhalational exposure to PLTX, is less common 
and foreseeable. The use of boiling water to remove invasive Palythoa 
corals from aquaria is a common habit among hobbyists. The use of 
this procedure on PLTX-containing zoanthids has exposed people to 
toxic aerosol with consequences like shortness of breath, chest pain and 
bronchospasm, as described by Deeds and Schwarz (2010). A similar 
case occurred also in New York (Majlesi et al., 2008) but the identity of 
the coral has never been confirmed. In Table II, are listed cases of 
intoxication with direct identification of PLTX-like compounds in the 
causing organisms. In particular, samples of O. ovata collected along 
the Liguria coasts during the “Algal Syndrome” revealed the presence 
of putative PLTX and Ovatoxin-A (Ciminiello et al., 2008), and 
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similarly, also in corals examined in USA, a PLTX-like compound was 
detected.  In all other cases, even if the species of microalgae or soft-
corals were identified, no toxin quantification was reported.  
Location, 
year 
Poisoning 
source 
Cases 
(n°) 
Outcome 
Symptoms and 
clinical data 
Reference 
Italy 
(Tyrrhenian 
Sea), 
2005 
O. ovata 209 Recovery  
(209/209) 
within  3 days 
Fever, sore throat, 
cough, dyspnoea, 
headache, nausea, 
rhinorrhea, 
lacrimation, vomiting, 
dermatitis. 
leukocytosis, 
neutrophilia 
Durando et 
al., 2007 
Italy 
(Tyrrhenian 
Sea), 
2006 
O. ovata 19 Recovery  
(19/19) 
within  3 days 
Cough, sore throat, 
dyspnoea, fever, 
rhinorrhea, nausea, 
headache, lacrimation, 
vomiting 
Durando et 
al., 2007 
USA 
(Virginia), 
2008 
Palythoa 
sp. 
1 Recovery  
(1/1) 
within 1 
month 
Foul odor. Shortness 
of breath and chest 
pain from 
bronchospasm  
Deeds and 
Schwartz, 
2010 
 
Table II. Inhalational exposure. Cases of intoxication with direct identification of the 
toxin (Tubaro et al., 2011a, modified). 
 
1.2.2.3. Dermal exposure 
 
As previously described for inhalational exposure, dermal exposure 
may occur after direct contact with the Palythoa corals or after contact 
with seawater containing Ostreopsis spp. The first typically occurs in 
home aquaria after contact with the soft corals the latter during working 
or recreational activities associated with the sea. Cases of dermatitis 
associated with the exposure to Ostreopsis spp. were usually 
documented together with inhalational exposure. Even if really 
widespread and probably underestimated for incidence, this symptom 
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seems to be less severe in comparison with the respiratory ones and it is 
often underestimated. Dermal contacts were described for aquaria 
hobbyists (Hoffmann et al., 2008), but also for researchers that 
collected the corals of Palythoa toxica (Moore and Scheuer 1971; 
Moore et al., 1982). The case described by Hoffmann and co-workers 
(2008) was probably more severe than others because the corals 
produced small cuts in the fingers of the patient, providing an access 
for the toxin to the systemic circulation. In fact, myalgia, 
electrocardiographic alterations and elevated serum levels of CPK and 
LDH were observed (Table III). 
Location, 
year 
Poisoning 
source 
Cases 
(n°) 
Outcome 
Symptoms and 
clinical data 
Reference 
Hawaii, 
USA, 
1962 
P. toxica 1 Recovery 
(1/1) 
within 1 week 
Malaise, dizziness, 
nausea, headache, and 
discomfort to the 
hands and feet 
Moore and 
Scheuer 
1971; 
Moore et 
al., 1982 
Germany, 
2008 
Parazo-
anthus sp. 
1 Recovery 
(1/1) 
within 48h 
Myalgia, dizziness, 
weakness of the 
extremities. Swelling 
and erythema of cut 
fingers with 
numbness of the arm. 
Abnormal ECG. 
Slightly elevated 
CPK, LDH, and CRP 
Hoffman et 
al., 2008 
Table III. Dermal exposure. Cases of intoxication with direct identification of the 
toxin (Tubaro et al., 2011a, modified). 
 
Symptoms similar to those described in Germany were recorded also in 
Georgia (Deeds and Schwarz, 2010) and California (Nordt et al., 2011), 
with chest pain, lightheadedness, weakness and numbness of the arm, 
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sinus tachycardia, elevated CPK in the first and perioral paresthesia, 
dysguesia, edema, erythema and pruritus of both hands, in the latter. 
Also  these cases  were ascribed to PLTX containing corals, but there 
are some uncertainties for specie identification and no quantification of 
the toxin was carried out. 
 
1.2.2.4. Ocular exposure 
 
In comparison to the other exposure/absorption sites, ocular mucosa is 
the less studied but, for sure one of the most sensitive ones. Ocular 
involvement has been described in several cases of inhalation exposure 
to Ostreopsis spp. Conjunctivitis (Di Turi et al., 2003; Durando et al., 
2007) and eye irritation (Kermarec et al., 2008; Barroso García et al., 
2008; Tichadou et al., 2010) have been recorded many times, but it was 
not clear if they could be attributed to a direct action of the Ostreopsis 
containing aerosol or to a secondary effect of the severe rhinorrhea. In 
2010, Moshirfar and co-workers described keratoconjunctivitis 
occurred in two patients while handling zoanthid corals in home 
aquaria (Moshirfar et al., 2010). Authors attributed the ocular damage 
to PLTX, but did not provide any chemical analysis of the coral or, at 
least, their precise taxonomical identification. The first patient 
experienced a metallic bitter taste while handling the coral, that is one 
of the most typical characteristic associated to PLTX-containing 
seafood (Alcala et al., 1988; Onuma et al., 1999). The day after, the 
patient developed eye pain, eyelid swelling, photophobia, and purulent 
discharge from both eyes. Recovery was slow (around 12 weeks) and 
not complete, possibly also for the presence of contact lenses that 
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increased exposure time to the toxic agent. The second case was very 
similar, for both exposure scenario (home aquaria cleaning) and effects, 
but resolved completely in two weeks treatment (Moshirfar et al., 
2010). Taken together, these data are far from provide a complete 
characterization of the effects of PLTX at ocular level, but, in spite of 
that, provide precious suggestion for the evaluation of the possible 
exposure scenarios and on the sensitivity of this tissue.  
 
1.3. Toxicity assessment 
 
1.3.1. In vitro studies 
 
For a better comprehension of the mechanism of toxicity of PLTX on 
biological systems the effects of the molecule have been investigated 
on several in vitro models. Considering that the Na
+
/K
+
 pump is 
expressed in all mammalian cells, toxicity has been observed in all cells 
tested, but with some peculiar differences in the mechanisms of action, 
related to cell type. 
 
1.3.1.1. Effects on excitable cells and tissues 
 
Immediately after the discovery of PLTX, its effects have been 
investigated on smooth muscular tissue and cells culture. Even though, 
in early studies, molecular weight of the toxin was estimated to be 
3,300 (Ito et al., 1979), data obtained before complete structural 
elucidation and purification of PLTX are in good agreement with those 
obtained after 1981. At macroscopic level, the toxin induces a sustained 
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contraction of muscular tissue described in a wide variety of samples, 
such as vascular, intestinal, tracheal and papillary smooth muscles (Ito 
et al., 1976; 1977; 1979; Ozaki et al., 1983; Ishida et al., 1985). PLTX-
induced contraction is recordable from concentrations in the picomolar 
range (Robinson and Franz, 1991; Robinson et al., 1992). Development 
of tension usually sets within seconds and is hard to be relaxed, even 
after toxin removal (Ito et al., 1977). Contraction appears to be 
dependent on external Ca
2+ 
but insensitive to commonly used relaxants, 
such as atropine, tripenelamine or tetrodotoxin, phentolamine, 
phenoxybenzamine (Ito et al., 1976; Ozaki et al., 1983). PLTX is also 
known to disrupt electrical properties of smooth muscle, causing 
persistent depolarization of cellular membrane  (Ito et al., 1977; 1979; 
Sheridan et al., 2005). In agreement with the proposed mechanism of 
action, the toxin induces K
+
 efflux from ileal smooth muscle (Hori et 
al., 1988). Moreover, contraction and intracellular Ca
2+
 increase 
([Ca
2+
]i) were found to be dependent on extracellular Na
+
 (Ozaki et al., 
1983; Ishii et al., 1997). According to this data, it was suggested that 
Na
+
 influx could trigger the activation of voltage-dependent Ca
2+
 
channels, Na
+
/Ca
2+
 exchanger and Ca
2+
 release from intracellular 
stores, leading to an [Ca
2+
]i  as a secondary event (Ishii et al., 1997). 
The direct involvement of the toxin on muscular contraction was 
supported from data obtained in vascular muscle pre-incubated with 
reserpine. Reserpine induces pre-synaptic release of norepinephrine and 
effects of PLTX in this condition suggest a mechanism of action 
independent from the release of endogenous neurotransmitters (Karaki 
et al., 1988). Beside impairment of electrical and mechanical 
properties, PLTX is also highly cytotoxic. Toxicity was observed at 
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nanomolar concentrations and was accompanied by huge morphologic 
changes such as vacuolation, rounding and development of granulation 
on cellular surface (Sheridan et al., 2005). 
The characterization of PLTX-induced ionic unbalance and toxicity has 
been quite deeply characterized in smooth muscles, on the contrary 
there are only few data that deal with skeletal muscle. Similarly to 
smooth muscle, also in skeletal tissue the toxin triggers an irreversible 
and Na
+
-sensitive membrane depolarization (Deguchi et al., 1976; 
Ecault and Sauviat, 1991). This event appears insensitive to blockers of 
voltage-dpendent Na
+
 channels, such as tetrodotoxin (TTX) and 
amiloride (Ecault and Sauviat, 1991).  
Similarly, in cardiac cells, PLTX induces depolarization of cellular 
membrane sustained by Na
+
 conductance (Sauviat et al., 1987; 
Muramatsu et al., 1988; Artigas and Gadsby, 2002). Na
+
 entrance in 
these cells seems to be the result of the interaction of the toxin with the 
Na
+
/K
+ 
pump, but also with the result of the contribution of the 
Na
+
/Ca
2+
 antiporter (Frelin et al., 1991; Frelin and Van Renterghem, 
1995). Beside Na
+
 current, PLTX was also reported to induce an 
outward K
+ 
current, occurring also in Na
+
-free solutions (Kinoshita et 
al., 1991). In line with previous results, it was demonstrated that the 
Na
+
 current elicited by the toxin needed external Ca
2+ 
for activation 
(Van Renterghem and Freling, 1993). In addition, it was also observed 
that PLTX promotes intracellular acidification, possibly as one of the 
extreme consequences of the primary ionic unbalance (Frelin et al., 
1990). Morover, it was also demonstrated on cultured cat myocytes, 
that the toxin disrupts excitation-contraction coupling at atrial level 
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(Kockskämper et al., 2004). Even if electrophysiological experiments 
have been performed extensively on cardiac cells, no data about the 
cytotoxicity of PLTXs in this model are currently available. 
Commonly to other excitable cells, also in neurons PLTX is known to 
induce membrane depolarization (Muramatsu et al., 1984; Kudo and 
Shibata, 1980; Louzao et al., 2006) insensitive or scarcely sensitive to 
TTX, and disappearing after removal of external Na
+
 (Muramatsu et al., 
1984). In primary cultures of neurons of the suprachiasmatic nucleus, 
the PLTX induces transient increase of spontaneous firing, followed by 
a total elimination of spontaneous spiking activity (Wang and Huang, 
2006). As secondary action of PLTX on the Na
+
/K
+
 pump and 
membrane depolarization, the toxin triggers an [Ca
2+
]i increase 
sensitive to nifedipine (blocker of voltage-dependent Ca
2+
 channels) 
and saxitoxin (blocker of voltage-dependent Na
+ 
channels), when 
present together in the bathing solution, before toxin addition. The 
uncontrolled increase of [Ca
2+
]i is usually precursor of high cytotoxic 
events and, in fact, PLTX induces release of exocytotic synaptic 
vesicles in cerebellar granule neurons (Vale et al., 2006). Moreover, in 
the same cellular model, it was also shown that PLTX decreases 
intracellular pH, possibly through the involvement of the plasma 
membrane Ca
2+
-ATP-ase (Vale-Gonzáles et al., 2007). The effect of the 
toxin has been investigated also in neuroblastoma cells. In order to 
deeper investigate the mechanism of cytotoxic action of palytoxin, 
typical apoptotic markers were evaluated, such as mitochondrial 
membrane potential, activation of caspases, DNA damage. The only 
parameter that resulted to be influenced by PLTX was mitochondrial 
membrane potential, suggesting minor importance for apoptotic 
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pathways in PLTX-induced cell death (Valverde et al., 2008). Similar 
conclusions were drawn also by Sagara and co-workers (2011), that 
suggested a non-oxidative necrotic damage to PC12 cells incubated 
with PLTX. As already described for primary cultures, also in 
neuroblastoma cells, PLTX and analogues trigger [Ca
2+
]i increase 
(Louzao et al., 2007). Moreover, this family of toxins also causes 
disorganization of filamentous actin (Louzao et al., 2007), and also of 
globular actin (Ares et al., 2009). 
 
1.3.1.2. Effects on non-excitable cells  
 
Since  Na
+
/K
+
 ATPase, is distributed in all mammalian cells 
(Horisberger, 2004), even if the primary action of the toxin is 
disruption of ionic equilibrium, also non excitable cells are heavily 
affected from these family of compounds.  
Among effects on non-excitable cells, particular scientific relevance 
has been given to the effects of PLTXs on erythrocytes. The ability of 
the toxin to induce delayed hemolysis is one of its most peculiar and 
distinguishing features, and has been extensively used for the detection 
of the toxin in several matrices, such as fish (Onuma et al., 1999; 
Gleibs and Mebs, 1999; Wachi et al., 2000) and shellfish (Aligizaki et 
al., 2008; 2011). The assay was developed from Dr. Bignami (1993), 
and later used and further developed also from other research groups 
(Riobò et al., 2008b; 2011).  
In culture, the toxicity of PLTX and PLTX-like compound has been 
demonstrated in a wide variety of cellular models. One of those are 
cultured intestinal cells (Valverde et al., 2008), whose sensitivity is 
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among the highest ever recorded, with an EC50, after only four hours of 
incubation, in the picomolar range (Pelin et al., 2012). Skin 
keratinocytes were also found to be a very sensitive target for PLTX. 
On this model PLTX is highly cytotoxic and induces the production of 
reactive oxygen species (ROS) (Pelin et al., 2011). Among the effects 
of PLTX on skin, particular attention should be given to the discovery 
that the toxin is also a skin tumor promoter. Generally skin tumor 
promoters involve the activation of the protein kinase C, exactly like 
the 12-O-tetradecanoylphorbol-13-acetate (TPA). PLTX is defined as a 
non-TPA tumor promoter, because it is a tumor promoter without 
activating the protein kinase C (Fujiki et al., 1986; Wattenberg, 2007). 
Also in this case, Na
+
 influx seems to play a crucial role in the 
mechanism of action of PLTX. In fact, experimental evidences suggest 
that the activation of stress activated protein kinase JNK require the 
monovalent cation (Kuroki et al., 1996).  
 
1.3.2. In vivo studies 
 
For more complete comprehension of the toxicological risk associated 
with the entrance of PLTX into the food web some in vivo studies were 
also performed. Unfortunately, many of the studies were carried out 
before complete structural elucidation of the molecule and, in some 
cases, a different molecular weight was reported (Wiles et al., 1974).  
A considerable amount of studies was performed on dogs, that are 
considered among the most sensitive species to this family of toxins. 
Intravenous administration of PLTX, isolated from different species of 
Palythoa, causes severe impairment of function of the cardiovascular 
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apparatus.  In more detail, the administration of extract of P. mamillosa 
(Kaul et al., 1974; Munday 2008), P. caribaeorum (Kaul 1981; 
Munday 2008) and P. tuberculosa (Ito et al., 1982) caused 
abnormalities of blood pressure and ECG profile, that finally lead to 
death for cardio-circulatory arrest. Similar alterations of the blood 
pressure and disturbances of the electrocardiographic profile were 
observed also in cats treated with PLTX isolated from P. tuberculosa 
with estimated molecular weight of 3300 Da (Deguchi et al., 1974).  
Parenteral administration (i.v.) of partially purified PLTX (m.w. 3300 
Da) isolated from P. vestitus to rats caused sedation, dyspnea and 
convulsion prior to death, with an LD50= 0.089 µg/kg and no effects 
were seen with the administration per os of the same toxin up to the 
dose of 40 µg/kg (Wiles et al., 1974).  
According to the available data, the most sensitive animal after 
intravenous administration of PLTX-like compounds  seems to be the 
rabbit with an LD50 of 0.025 µg/kg (Wiles et al., 1974). This result 
presents some uncertainties, once again due to the limited purification 
of the toxin, but nevertheless, it allows to classify PLTX as one of the 
most dangerous natural toxin ever isolated.  
Administration of the toxin  via intra-tracheal route was also reported. 
Literature offers few example in this respect. Intra-tracheal 
administration of toxins from P. vestitus in rats, elicited symptoms and 
toxicity similar to those observed after i.v. administration, with an DL50 
of 0.63 µg/kg (Wiles et al., 1974). Similarly, Ito and Yasumoto, 
observed death of mice within 2 hours from the administration of 
commercial PLTX, starting from the dose of 2 µg/kg. Thus, mortality 
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was recorded at a dose 100 times lower than that recorded after gavage 
administration, and symptoms were paralysis, alveolar bleeding and 
gastro-intestinal erosion (Ito and Yasumoto, 2009).  
Mouse is probably the most used experimental model for the 
investigation of in vivo toxicity. Among literature studies, only few of 
them were performed with commercial PLTX and the other were 
performed with toxins purified with different protocols from several 
sources, without any information about purity. The majority of the data 
describe the effects of the toxin after intra-peritoneal (i.p.) 
administration. The i.p. administration of different doses of pure PLTX 
caused mortality in the nanomolar range and the Lethal Dose for the 
50% of the treated animals (LD50) was found to be around 0,31µg/kg 
(Riobò et al., 2008b) and 0,72µg/kg (Rhodes et al., 2002). Main 
symptoms were abnormal gait (Riobò et al., 2008b; Rhodes et al., 
2002), convulsions and breathing difficulties (Riobò et al., 2008b). 
Similar symptoms were described also for toxin isolated from Demania 
alcalaii (Ito et al., 1996), from extracts of Ostreopsis mascarenensis 
(Lenoir et al., 2004), Palythoa toxica (Munday 2008), Scarus ovifrons 
(Tanyiama et al., 2003) and Lophozozimus pictor (Chia et al., 1993).  
Studies after oral administration in mice are more informative for the 
investigation of the potential threat related to the entrance of PLTX into 
the food chain, but data in this respect are more limited in number. 
Initially, LD50 was calculated with the “up and down” method to be 510 
µg/kg (Munday, 2008). Later, to obtain more information about the 
target organs of these compounds, a study was performed in our 
laboratory following the “classical method” for the acute toxicity 
testing (Sosa et al., 2009). Toxin was administered per os, and 
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calculated LD50, according to the Finney method (Finney, 1971), was 
767 µg/kg. Symptoms observed were in good agreement with those 
described after i.p. administration, such as paralysis, convulsions and 
severe breathing difficulties (Sosa et al., 2009). Similar toxicity (LD50, 
650 µg/kg) was observed also in mice treated with 42-OH-PLTX 
(Tubaro et al., 2011b). In this context, more detailed experiments to 
investigate the mechanism of action of PLTXs have been performed 
revealing the muscular apparatus as one of the target organs of the 
molecule also in mouse (Figure 6). 
     
A. Control                      B.42-OH-PLTX                      C. PLTX 
Figure 6. Electron micrographs of skeletal muscle (A) control mouse; (B) 42-OH-
PLTX treated mouse dose 424µg/kg; (C) PLTX treated mouse dose 1200 µg/kg; scale 
mark: 1µm. 
 
 
 
 
 
 
 
 
49 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. AIM  
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On the whole, the present project was developed to contribute to the 
definition of risk characterization of PLTX and analogues as seafood 
contaminants. 
From the epidemiological data describing the effects of the ingestion of 
PLTX-contaminated seafood, it results clear that one of the peculiar 
and distinguishing characteristic of the intoxication is the 
damage/impairment of the skeletal muscle. In spite of this evidence, the 
mechanism of toxicity of this family of compounds on skeletal muscle 
has never been studied in detail. For this reason, to complete risk 
characterization and to implement the information about the 
mechanism of action of PLTX and analogues, one of the target of the 
present project was the elucidation of the mechanism of toxic action of 
PLTXs on primary cultures of mouse skeletal muscle cells.  
From the exposure assessment emerges that these toxins, initially, 
detected only in tropical and subtropical areas, are more and more 
frequently found in seafood collected and commercialized in temperate 
seas. This geographic shift, poses new concerns from scientific and 
regulatory point of view. In fact, together with the growing interest of 
the scientific community for this family of compounds, there is also an 
alarming gap regarding their regulation. In Europe, some efforts have 
been made to try to fulfill legislative empty spaces with the publication, 
in 2009, of a scientific opinion by European Food Safety Authority 
(EFSA, 2009). The experts gave a general evaluation of the molecule 
suggesting, from the available data, an Acute Reference Dose (ARfD) 
for mixed PLTXs and Ostreocins of 0.2 μg/kg b.w. These data were 
calculated starting from an acute toxicity study and in particular from a 
LOAEL (Lowest Observed Adverse Effect Level) published by Ito and 
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Yasumoto (2009) of 200 µg/kg of toxin given orally to mice. In spite of 
that, the absence in literature of scientific studies that describe the 
effects of repeated oral intake of PLTXs, represents a sever limitation 
in the development of the risk assessment. Indeed, it is possible that 
toxins accumulate in different species of seafood in the same 
geographical area. For this reason, consumers, according to personal 
habit, may come into contact with toxin more than once and, in this 
case, only testing the effects of repeated administration could help in 
the comprehension of the real hazard associated to the exposure. 
Moreover, toxicity studies are necessarily the basis for the calculation 
of regulatory limits for the presence of biotoxins in seafood and, as a 
consequence, gives also the range of sensitivity that detection methods 
should have for monitoring purposes. In light of this, the second goal of 
the present project  was to investigate sub-acute toxicity  of PLTX.  
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3.1. Materials 
 
3.1.1. Toxins 
 
Palytoxin (declared purity of more than 90%) was purchased from Wako 
Chemicals GmbH (Neuss, Germany).  
42-OH-PLTX was a non-commercial sample and has been kindly provided by 
Dr. Mark Poli of the US AMRID; the toxin was provided in frame of a 
bilateral agreement between University of Trieste and the American 
USAMRID.  Briefly, the sample 42-hydroxy-palytoxin was obtained from 
Palythoa toxica collected in Hawaii, according to the procedure described by 
Moore and Scheuer (1971) and modified by Bignami et al. (1992). The toxin 
was extracted from P. toxica with 70 % aqueous ethanol. The extract thus 
obtained was concentrated in vacuo and then extracted with dichloromethane. 
The toxic fraction was purified from the aqueous layer by column 
chromatography on Amberlite XAD-2, followed by chromatography on 
DEAE-Sephadex A-25 and CM-Sephadex C-25. The toxic fraction was 
finally desalted on Bond Elut C18 eluted with 80 % aqueous ethanol. The 
analysis of the toxins have been carried out by the research group of Prof. 
Ciminiello and Prof. Fattorusso at the University Federico II of Neaple and 
details are reported in Ciminiello et al., 2009 (purity more than 90%). 
Ostreocin-D has been kindly gifted from Prof. Takeshi Yasumoto (Japan Food 
Research Laboratories, Tama Laboratory, Tokyo, Japan). 
For in vivo toxicity studies, PLTX was dissolved in phosphate buffered saline 
(PBS), pH 7.0. To avoid chemical instability, solutions were prepared every 
morning immediately before administration to the animals. 
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For in vitro studies toxins were stored in glass vials, in aqueous/ethanol 
solution (1:1) at -20°C. The day of the experiment working dilutions were 
freshly prepared according to experimental protocol.  
 
3.1.2.  Animals 
 
Female CD-1 mice (18–20 g body weight, 4 weeks old) were purchased from 
Harlan Italy (S. Pietro al Natisone, Italy). Animals were acclimatized in our 
facilities for 2 weeks before treatment. Animal room controls were set to 
maintain controlled temperature (21 ± 1°C) and humidity (60-70 %). The 
room was illuminated with a fixed artificial light cycle (7.00 a.m.–7.00 p.m.). 
Animals were caged, in groups of 6, using dust free poplar chips for bedding 
and fed with the standard diet for rodents (Harlan Italy, S. Pietro al Natisone, 
Italy). Diet composition, as indicated by Harlan Italy, was: proteins (18.5 %), 
fats (5.5 %), fibers (4.5 %), hashes (6.0 %), non-nitrogen compounds (53.5 
%), water (12.0 %). Dietary supplements present in fed are listed in table IV. 
Water and fed were provided ad libitum during all phases of the study. 
Experiments were carried out at the University of Trieste in conformity with 
Italian D.L. n. 116 of 27 January 1992 and associated guidelines in the 
European Communities Council Directive of 24 November 1986 (86/609 
ECC), concerning animal welfare and appendix A of the European 
Convention ETS 123.  
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Ingredient Quantity Ingredient Quantity 
Vitamin A 15,000 UI Pantothenic acid 21.0 mg 
Vitamin D
3
 1,500 UI Colin 300.0 mg 
Vitamin B
1
   9.8 mg Folic acid 3.0 mg 
Vitamin B2 12.0 mg Iron 50.0 mg 
Vitamin B
6
 11.5 mg Manganese 44.0 mg 
Vitamin B
12
 0.08 mg Zinc 30.0 mg 
Vitamin E 81.0 mg Copper 7.0 mg 
Vitamin H 0.23 mg Cobalt 0.5 mg 
Vitamin K3 50.0 mg Iodide 6.1 mg 
Vitamin PP 27.0 mg Chromium 0.5 mg 
 
Table IV. Supplementary ingredients of animals fed. 
 
3.1.3. Reagents 
 
Bovine fetal calf serum (FCS) was from PAA Laboratories (Mascia Brunelli; 
Milan, Italy). The ion channels blockers cyclopiazonic acid, gadolinium, 
lanthanum and cadmium were purchased from Sigma (Milan, Italy). 
Verapamil, KB-R7943, SKF-96365 and tetrodotoxin (TTX) were from Tocris 
Bioscience (Bristol, UK).  
Mouse monoclonal anti-desmin antibody D33 was from Dako (Glostrup, 
Denmark) and Rhodamine-conjugated goat anti-mouse IgG was from Jackson 
ImmunoResearch Laboratories (Suffolk, UK).  
[
3
H]-ouabain (specific activity 30 Ci/mmol) was from Perkin Elmer Italia 
(Monza, Italy).  
If not otherwise specified, other chemicals were from Sigma (Milano, Italy). 
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Technical details of instruments used in the present thesis are reported in 
specific methods sections. 
 
3.2. Methods 
 
3.2.1. In vitro studies 
  
3.2.1.1. Primary culture of skeletal muscle cells  
 
Cultures were established from mouse satellite cells (Irintchev et al., 1997). 
Briefly, myoblasts were isolated from the hind leg muscles of 7-day-old male 
Balb/c mice killed by cervical dislocation as approved by the local Animal 
Care Committee  and in agreement with the European legislation. Muscle 
tissue was minced and then treated with collagenase and trypsin. Expansion 
and enrichment of desmin-positive cells was achieved by repeated plating and 
cultivation in Dulbecco’s modified minimal essential medium (DMEM) with 
D-valine containing 20% FCS. Myoblasts were maintained as exponentially 
growing cells in the presence of medium consisting of HAM’S F-10 
containing 20% FCS, L-glutamine (2 mM), penicillin (100 units/ml), and 
streptomycin (100 mg/ml). To induce cell differentiation and fusion of 
myoblasts into myotubes, the medium was replaced with DMEM 
supplemented with 2% horse serum and L-glutamine, penicillin, and 
streptomycin as above. Undifferentiated and differentiated cells were 
maintained at 37°C in CO2 (5%)-enriched air (Lorenzon et al., 2002; Luin and 
Ruzzier, 2007). 
Experiments were performed on differentiated on myotubes between the 5
th
 
and the 8
th
 day after plating. In these experimental conditions, spontaneous 
contractile activity was detectable as cell twitches clearly visible using a 
bright field microscope (20X objective). 
57 
 
3.2.1.2. Sulforhodamine B assay  
 
Experiments were performed according to Dell’Ovo et al. (2008). Cells seeded 
in 96-wells microplates and treated with PLTX or 42-OH-PLTX according to 
the experimental protocol. At the end of cell treatments medium was removed. 
Cells were rinsed twice with PBS (100 µl), and ﬁxed with 50 µl of 50% 
trichloroacetic acid (1 hour, 4°C). After fixation, cells were rinsed twice with 
twice-distilled water (100 µl), and an equal volume of sulforhodamine B (SRB, 
0.4% in 1% acetic acid) was added. After 30 min, cells were rinsed three times 
with acetic acid (1%) and solubilised with 200 µl Tris (10 mM). Sample 
absorbance was read on an Automated Microplate Reader EL 311s (Bio-Tek 
Instruments; Winooski, VT) with a single wavelength of 570 nm. If not 
otherwise specified,  experimental results are expressed as mean of at least four 
independent experiments performed in triplicate ± SE. 
 
3.2.1.3. May-Grunwald Giemsa stain 
 
At the end of treatment, cells were immediately fixed in methanol for 1 minute 
to stop progression of the cellular damage. Staining was started incubating cells 
for 5 minutes with the May-Grunwald solution. Colour excess was removed 
rinsing twice the dish with PBS. Second stain was performed with Giemsa 
solution  diluted in PBS (2 times 7 minutes). At the end of incubation cells were 
rinsed twice with distilled water and dried prior to observation. 
 
3.2.1.4. Atomic Force Microscopy  
 
Single cells were analyzed using a Solver-Pro M (NT-MDT, Moscow, Russia) 
atomic force microscope. Living cells were scanned in a contact mode. The 
AFM cantilever was equipped with a PNP-DB silicon nitride tip (Nanoworld, 
Neuchâtel, Switzerland). Scan time was 10 minutes for 100x100 µm
2
, with a 
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resolution of 256x256 points and pixel size 0,4x0,4 μm2. The AFM was 
equipped with liquid scanning set-up and measurements were performed at 
room temperature. Cells were maintained in NES solution (for details see 
section Videoimaging) for the whole experiment. With a Solver-Pro controller it 
is possible to have multiple types of measurements during a single scan. For the 
purposes of this study, the variation of displacement along the z-axis has been 
recorded during the outward and return scan. Moreover the variation of lateral 
force (LF) was also acquired. 
 
3.2.1.5. Videoimaging  
 
Videoimaging experiments were carried out according to Lorenzon et al. (2002). 
Cells were plated on glass coverslips coated with Matrigel. Loading of the Ca
2+
 
indicator fura-2 pentacetoxymethylester (fura-2 AM) was performed by 
incubating cells (30 min, 37°C) in a normal external solution (NES) 
supplemented with 1 mg/ml of bovine serum albumin and 5 mM fura-2 AM. 
After loading, cells were rinsed and maintained in NES for an additional 15 min 
at 37 °C to allow de-esterification of the dye. Experiments were performed in 
NES complete or with modified ionic composition, according to experimental 
purposes  (Table V).  
 
SOLUTION 
  Na
+ 
(mM) 
   K
+ 
(mM) 
 Ca
2+ 
(mM) 
 Mg
2+ 
(mM) 
  Cl
- 
(mM) 
Hepes 
(mM) 
Glucose 
 (mM) 
pH 
NES   140   2.8     2     2 150.8    10     10 7.35 
NES 
Ca
2+
 free 
  140   2.8     -     4 150.8    10     10 7.35 
NES 
Na
+
 free 
     -   2.8     2     2 150.8    10     10 7.35 
NES 
Cl
-
 free 
  140   2.8     2     2     -    10     10 7.35 
 
Table V. Ionic composition of normal external solutions (NES). 
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Ca
2+
 salts were substituted with Mg
2+
, NaCl was replaced with  N-methyl-D-
glucamine chloride in Na
+
-free solution. In Cl
-
-free solution, all chloride salts 
were replaced with  gluconate (K
+
) and sulphate salts (Na
+
, Mg
2+
 and  Ca
2+
) 
according to Jared et al. (2009), with slight modifications. The concentration 
and the composition of the cationic components were kept constant. 
PLTXs and blockers (verapamil; KB-R7943; SKF-96365; lanthanum and 
cadmium; TTX), except those preincubated (ouabain, cyclopiazonic acid and 
gadolinium), were gently applied to the bathing solution by loading appropriate 
volumes of concentrated solution into a 5-ml syringe connected to the micro-
incubator chamber. For all drugs, preliminary control experiments were 
performed to select a protocol (working concentrations and time exposures) that 
did not cause per se cell toxicity. The digital fluorescence-imaging microscopy 
system consisted of an inverted microscope (Zeiss Axiovert 135; Oberkochen, 
Germany) equipped with an intensified CCD camera (Hamamatsu Photonics; 
Hamamatsu, Japan). A temperature-controlled micro-incubator chamber 
(Medical Systems Corporation; Davie, Fl) maintained the temperature at 37 °C 
during the experiments. Loaded cells were alternatively excited at 340 and 380 
nm by a modified dual wavelength microfluorimeter (Jasco CAM-230; Tokyo, 
Japan). The ratio of corresponding images at 340 and 380 nm and the temporal 
plots of the fluorescence signal were calculated offline. Being image acquisition 
performed at two frames/second, our time resolution was one ratio 
image/second. In the temporal plots (i.e. fluorescence ratio vs time), the 
fluorescence ratio at rest was assumed to be 1. Variation of the [Ca
2+
]i was 
expressed as increase in fluorescent signal relative to the fluorescence ratio at 
rest. Each set of experiments was  carried out on at least three different cell 
preparations. Each experimental point was expressed as mean ± SE, with n 
being the number of cells tested.  
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3.2.1.6. Immunocytochemistry  
 
Myotubes were fixed in paraformaldehyde (3.7% in PBS; 15 min), 
permeabilized with 100% methanol and then incubated with a mouse 
monoclonal anti-desmin antibody (60 min; 1/50 dilution). For visualization, 
cells were then incubated at room temperature with Rhodamine-conjugated goat 
anti-mouse IgG (60 min; 1/200 dilution). For nuclear staining, bis-Benzimide H-
33258 (5 min; 1/1000 dilution) was used. Slides were observed with a standard 
fluorescence microscope (40X objective). Observations were performed on two 
different cell preparations.  
 
3.2.1.7. Binding experiments 
 
Binding experiments were performed on differentiated myotubes seeded in 24-
wells microplates. To determine the characteristic of ouabain binding of in our 
cellular model, preliminary experiments were performed: time-course and 
concentration dependence were verified before performing experiments with 
toxins. Once optimized incubation time and concentration of tritiated ligand, 
experiments were performed to measure the ability of PLTXs to displace [
3
H]-
ouabain from its binding site. To reach equilibrium between bound and unbound 
[
3
H]-ouabain cells were pre-incubated with 100 µM of the ligand for 90 min. 
Displacement reaction started with the addition of increasing concentrations of 
PLTXs. Both toxins and [
3
H]-ouabain were diluted in NES (composition in 
Table V, section 3.2.1.5.  Videoimaging). At the end of incubation (90 minutes 
at 37°C), the reaction was blocked by fast aspiration of the surnatant. Cells were 
rinsed twice with ice cold buffer in order to remove unbound [
3
H]-ouabain. At 
this point, cells were lysed with 250 µL NaOH (1 M) supplemented with 1% 
Sodium Dodecyl Sulphate. The lysate (200 µL) was then transferred in a 
reading plate and SuperMix scintillation cocktail was added (250 µL per well). 
The plate was read in a MicroBeta Trilux counter (Wallac, Turku, Finland). In 
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parallel, to ensure that cellular viability  was not decreased during the treatment, 
event that per se would trigger cellular detachment and decrease [
3
H]-ouabain 
binding, cytotoxicity assessment was also performed. Twenty-four wells 
microplates, identical to that used for binding experiments, were incubated with 
toxins and cold ouabain to exactly as in binding experiments. At the end of 
incubation cellular mass was measured with SRB assay, following the protocol 
described in section 3.2.1.2. 
 
3.2.1.8. Statistical analysis  
 
Data are given as means ± SE. The Student’s t test was used to examine 
statistical significance at p < 0.05 level.  
 
3.2.2.  In vivo studies 
 
3.2.2.1. Experimental design 
 
Groups of six female mice were treated at each dose level of PLTX (30, 90, 
180 µg/kg) or vehicle (PBS). The toxin was administered daily by gavage at 
10 ml/kg, adjusted on the basis of mouse weight. Control animals received the 
vehicle alone (PBS) at the same volume.  After dosing, the mice were 
observed at regular intervals. Symptoms and mortality were recorded every 30 
minutes within the first 3 hours post administration and again at longer times. 
Body weight and cage food consumption were recorded daily in the morning, 
before treatment. After 7 days of treatment, animals were weighed and 
anesthetized with ketamine hydrochloride and sacrificed (350 mg/kg; 
Inoketam100; Virbac; Milan, Italy). The main organs (see paragraph 2.6) 
were removed weighed and fixed in neutral buffered 10 % formalin. Animals 
that died during the observation period were immediately weighed and 
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necropsied; as previously described, the main organs and tissues were 
collected, weighed and fixed for the histological evaluations. 
 
3.2.2.2. Recovery 
 
In order to evaluate progression or recovery of the changes induced by the 
administration of PLTX some mice of each dose group were kept for a 14-day 
withdrawal period. As previously described, lethality symptoms, food 
consumption and body weight were recorded daily. After 14 days, mice were 
subjected to necropsy; the main organs and tissues were collected weighted 
and fixed for histological evaluations (see paragraph 3.2.2.3.).  
 
3.2.2.3. Light microscopy 
 
Heart, liver, lungs, kidneys, spleen, stomach, duodenum, jejunum, colon, 
rectum, pancreas, thymus, cerebrum, cerebellum, spinal cord, uterus, ovaries 
and skeletal muscle (soleus) were embedded in paraffin and sectioned (5 µm). 
Sections were deparaffinized, rehydrated and stained with haematoxylin-
eosin, following standard techniques for histological analyses by light 
microscopy. Histopathological examination by light microscopy was carried 
out in a blinded study. Pictures were obtained with a Nikon eclipse i 50 
microscope equipped with a DS-Vi1 digital camera and  NIS-Elements 
Microscope Imaging Software (all from  Nikon Instruments Europe)  and 
presented at the magnitude indicated in the legends. 
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4. RESULTS 
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4.1. Results in vitro 
4.1.1. Toxicity of  PLTXs  on differentiated skeletal muscle cells 
In order to characterize the toxicity induced by PLTX and 42-OH-
PLTX, the two molecules were tested on primary cultures of 
differentiated skeletal muscle cells (Figure 7 and 8).  
 
Figure 7. Toxicity of PLTX on mouse skeletal muscle cells assessed by 
sulforhodamine B assay. (A) Cell survival after 24 hours of exposure to increasing 
concentrations of PLTX. (B) Cell survival after 1, 2, or 4 hours of exposure to PLTX 
(1 nM) and recovery up to 24 hours in toxin-free medium compared to 24 hours of 
continuous exposure. 
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The toxic effect of PLTX and 42-OH-PLTX was measured using the 
sulforhodamine-B after 24 hours of incubation (Figure 7A and 8A).  
 
Figure 8. Toxicity of 42-OH-PLTX on mouse skeletal muscle cells assessed by 
sulforhodamine B assay. (A) Cell survival after 24 hours of exposure to increasing 
concentrations of PLTX. (B) Cell survival after 1, 2, or 4 hours of exposure to PLTX (1 
nM) and recovery up to 24 hours in toxin-free medium compared to 24 hours of 
continuous exposure. 
 
Both toxins induced cellular damage already at subnanomolar 
concentrations. Starting from the concentration of 0.012 nM the 
spontaneous contractile activity of the cultured myotubes, visible in 
bright field microscopy as cell twitching, was completely abolished. 
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However, at this concentration, the cellular damage was hardly 
appreciable at morphological level.  
PLTX and 42-OH-PLTX caused a concentration-dependent decrease of 
cell viability, detectable from the concentration of 0.037 nM. At this 
concentration, the mean reduction of viable cells was around 20% 
(Figure 7A and 8A). A 100 % toxicity was observed after incubation 
with PLTXs at the concentration of 3 nM or higher. 
From the analysis of the data the mean Effective Concentration on the 
50 % of the cellular population (EC50) was estimated as: 
EC50 (PLTX) = 0.54 nM ± 0.07 
EC50 (42-OH-PLTX) = 0.36 nM ± 0.06 
In order to establish if the cellular damage induced by PLTXs was 
directly related to the presence of the toxin into the cellular medium or, 
if a short time exposure could be sufficient to trigger the toxic effect, a 
second set of experiments was planned. In more detail, toxins were 
added to the culture medium for a short time (1, 2 or 4 hours) and then 
removed rinsing culture wells. Complete, toxin-free, medium was then 
restored and cellular viability was measured after 24 hours of recovery. 
The withdrawal of the toxin from the culture medium did not influence 
the development of cytotoxicity in the following 24 hours (Figure 7B 
and 8B). Thus, the brief exposures of skeletal muscle cells to PLTX and 
42-OH-PLTX induced a decrease in cell viability similar to that 
recorded after 24 hours of continuous exposure. 
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4.1.2. Effects of PLTXs on the cell morphology  
 
During toxicity studies, it was evident that differentiated skeletal 
muscle cells underwent prominent morphologic changes.  After the 
addition of the toxins to the culture medium, cellular rounding and 
vacuolation were observed within few hours (Figure 9). 
 
   
A. Control B. PLTX  C. 42-OH-PLTX  
 
Figure 9. Light micrographs of skeletal muscle cells. Control condition (A) or after 2 
hours incubation with 1 nM PLTXs (B, C). May-Grunwald Giemsa Stain. 40x. 
 
The morphology of the treated cells, obtained with the immunolabeling 
for the intermediate filament desmin, confirmed the harmful effect of 
the toxins. After treatment with PLTXs (24 hours, 0.1 nM), 
disorganisation of the desmin architecture, associated with a loss of the 
normal fibre shape, was observed in comparison to controls (Figure 
10).  
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Figure 10. Effect of PLTXs on cytoarchitecture of mouse skeletal muscle cells. 
Representative images of control culture (A) and  after incubation for 24 hours with 
0.1 nM PLTX (B) and 42-OH-PLTX (C). Cells were stained for desmin (red) and 
nuclei (blue). See Materials and Methods for further details. Magnification 20X in 
(A), (B) and (C). 
 
To quantify the progression of the morphological alteration of the cells 
incubated with PLTX, a series of experiments with atomic force 
microscope was performed. The variation of displacement along the z-
axis was recorded during the outward and return scan. Cells were 
scanned before toxin addition, as control (Figure 11A), and after toxin 
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application to the external bathing solution (Figure 11B-F) up to 50 
minutes post-exposure. Experiments revealed a mean increase of 
cellular volume of 9.0 ± 3.4 % (n = 5 cells) associated to cell swelling. 
 
 
Figure 11. Atomic force microscopy of skeletal muscle cells. Representative 3 
dimension image of a skeletal muscle cell in control conditions (A) and after the 
addition of 6 nM PLTX (B- F). Axes: x 0-100 µm, y 0-100 µm, z 0-6 µm. 
 
In addition, a decrease adherence of the cells was noticed. Loss of cell 
adhesion determined cellular shift during the acquisition as revealed by 
70 
 
the comparison between outward (Figure 12A) and return scan (Figure 
12B).  
 
  
  
 
Figure 12. Atomic force microscopy of skeletal muscle cells. Representative cellular 
shift during acquisition after 50 min of incubation with 6 nM (axes: x 0-70 µm, y 0-60 
µm, z 0-6 µm). The same cell is shown in 2 D (upper panel) and in 3 D (lower pannel)  
A. Acquisition during outward scan. B. Acquisition during return scan. 
 
4.1.3. Effect of PLTXs on cell response to Acetylcholine 
 
In order to evaluate the functional activity of skeletal muscle cells after 
exposure to PLTXs, the responsiveness of myotubes to the 
neurotransmitter acetylcholine (ACh) was tested. In physiological 
condition, the neurotransmitter ACh binds to the ionotropic receptors 
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expressed in skeletal muscle cells; the binding of ACh causes a 
conformational change of the receptor that allows a Na
+ 
influx into the 
cell. The Na
+
-mediated depolarization triggers the opening of the 
voltage-sensitive Ca
2+
 channels  and, consequently, an increase of the 
[Ca
2+
]i. In line with this, cellular response to ACh was assessed 
measuring the [Ca
2+
]i by the videoimaging technique (Figure 13). 
All the experiments were performed after 24 hours of incubation with 
the toxins at concentration of 0.1 nM. This concentration was chosen 
because, even if the cellular damage was already appreciable, the 
viability was maintained in approximately 80 % of the cells (Figure 7A 
and 8A). Cells incubated with the two toxins maintained the same 
sensitivity to ACh observed in controls (100 %). In spite of that, the 
amplitude of the [Ca
2+
]i transients elicited by the neurotransmitter was 
considerably reduced in cells treated with PLTXs, being 6 times lower 
(Figure 13A). In control dishes, the mean value of the [Ca
2+
]i increase 
after the addition of ACh (20 µM) was 130.2  ± 11.8 % (n = 37 cells); 
the mean [Ca
2+
]i increase in  the cells incubated with PLTX (0.1 nM) 
was approximately 21.8 ± 5.8 % (n = 20 cells). The ACh response in 
the cells incubated with 42-OH-PLTX was significantly higher than 
that of the cells treated with the parent PLTX. In particular, the 
amplitude of the transient was almost 3 times higher than that obtained 
with PLTX treated cells (65.6 ± 13.2 %; n = 38 cells; Figure 13B). 
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Figure13. Functional response of skeletal muscle cells after incubation with PLTXs. 
(A) Representative temporal plots of the Ca
2+
 response induced by ACh (20 μM) in 
control conditions and after 24 hours incubation with 0.1 nM PLTX (n = 20 cells) or 
42-OH-PLTX (n = 38 cells).  (B) Mean increase of [Ca
2+
]i  after the stimulation with 
ACh (20 μM) in cells incubated for 24 hours with 0.1 nM PLTX (n = 20 cells) or 42-
OH-PLTX (n  = 38 cells) in comparison to controls (n = 37 cells; * and ** p < 0.05 at 
the Student’s t-test as compared to controls). 
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4.1.4. [Ca
2+
]i increase induced by PLTXs  
 
PLTX and 42-OH-PLTX caused a significant biphasic increase in [Ca
2+
]i 
(Figure 14 and 15). Changes in [Ca
2+
]i levels began with a transitory 
increase (transient phase). The transient usually peaked within 20 s and 
was followed by a slower increase that reached a plateau within 300 s and 
remained unchanged even 30 minutes after the toxin application (long-
lasting phase). Even if the kinetic of PLTX-induced [Ca
2+
]i increase was  
quite reproducible, with the two phases clearly distinguishable, the 
amplitude of the increase resulted to be more variable. Rise in [Ca
2+
]i 
reached during transient and long-lasting phases can range from values 
around 50 % to nearly double, with an increase of 100 %. 
 
 
Figure14. Effect of PLTX on the [Ca
2+
]i of mouse skeletal muscle cells. Representative 
temporal plot of the biphasic [Ca
2+
]i increase induced by PLTX (6 nM). 
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 Figure15. Effect of 42-OH-PLTX on the [Ca
2+
]i of mouse skeletal muscle cells. 
Representative temporal plot of the biphasic [Ca
2+
]i increase induced by 42-OH-PLTX 
(6 nM). 
 
Dose-response experiments revealed a good correlation between the 
concentration of toxins used in the experiments and the number of 
responsive cells, in a concentration range between 0.67 and 6 nM. 
(Figure 16).  
 
Figure 16. Cell responsivity to PLTXs. The percentage of responsive cells in terms of 
increase of the [Ca
2+
]i  after the addition of PLTXs to the extracellular medium followed 
a dose-response relationship (each experimental point is mean of at least n = 20 cells 
observed). 
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At the concentration of 0.67 nM, the number of responsive cells was 
around 10 % and reached the maximum at the concentration of 6 nM.  
 
4.1.5. Contribution of extracellular Na
+
 and Ca
2+
 in the   
mechanism of action of PLTXs 
 
In order to investigate the influence of extracellular sodium ([Na
+
]e) in 
PLTXs-induced [Ca
2+
]i increase, experiments were performed in 
absence of the extracellular cation. The absence of Na
+
 in the 
extracellular solution (for further detail see Materials and Methods), 
completely abolished the [Ca
2+
]i increases triggered by the two toxins 
(Figure 17 and 18).  
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Figure 17. Effect of Na
+
-free on PLTX and 42-OH-PLTX induced  [Ca
2+
]i transients. 
Representative temporal plots of the [Ca
2+
]i variations induced by 6 nM PLTX (A) and 
42-OH-PLTX (B),  in the presence or in the absence of [Na
+
]e.  
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Figure 18. Effect of Na
+
-free on cell response to PLTX and 42-OH-PLTX. . 
Percentage of responsive cell (A) and [Ca
2+
]i increase (B) after addition of 6 nM 
PLTXs in control conditions (black) or in the absence of  [Na
+
]e (white) (* p < 0.05 in 
comparison to 6 nM PLTXs as control; n = 15 cells). 
 
Since in Na
+
-free solution PLTXs-induced [Ca
2+
]i increase was 
completely abolished, the influence of the role of voltage-dependent 
Na
+
 channels was investigated. To this aim, the widely used blocker 
TTX was employed. TTX 1 M completely abolished the cellular 
response to PLTX (Figure 19A and 20; n = 19 cells).  On the contrary, 
42-OH-PLTX was still able to trigger a transient [Ca
2+
]i increase 
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(Figure 19B and 20; n = 19 cells), but lower than that elicited by the 
toxin alone.   
 
Figure 19. Effect of TTX on PLTX and 42-OH-PLTX induced [Ca
2+
]i transients.. 
Representative temporal plots of the biphasic [Ca
2+
]i increase induced by 6 nM PLTX 
(A) and 42-OH-PLTX (B)  in the absence or in the presence of 1 M TTX. 
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Figure 20. Effect of TTX on cell response to PLTX and 42-OH-PLTX. Percentage of 
responsive cell (A) and [Ca
2+
]i increase (B) after addition of 6 nM PLTXs  alone  
(black) or in the presence of 1 µM TTX (white)  (* p < 0.05 in comparison to 6 nM 
PLTXs as control; n = 19 cells). 
 
A set of videoimaging experiments were also performed in the absence 
of extracellular Ca
2+ 
([Ca
2+
]e; Figure 21 and 22). 
As previously described for experiments performed without [Na
+
]e, also 
in the absence of [Ca
2+
]e the cellular answers triggered by PLTX and 
42-OH-PLTX were completely abolished (Figure 21 and 22). 
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Figure 21. Effect of Ca
2+
-free on PLTX and 42-OH-PLTX induced  [Ca
2+
]i transients. 
Representative temporal plots of the [Ca
2+
]i increase induced by 6 nM PLTX (A) and 
42-OH-PLTX (B),  in the presence or in the absence of [Ca
2+
]e . 
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Figure 22. Effect of Ca
2+
-free on cell response to PLTX and 42-OH-PLTX. 
Percentage of responsive cell (A) and [Ca
2+
]i increase (B) after addition of 6 nM 
PLTXs in the presence (black) or in the absence of [Ca
2+
]e  (white). (* p < 0.05 in 
comparison to 6 nM PLTXs as control; n = 15 cells). 
 
A number of experiments was planned to analyse the cytotoxicity 
induced by PLTXs in the absence of [Na
+
]e or [Ca
2+
]e. SRB assay 
revealed that the absence of Na
+ 
or Ca
2+
 in the extracellular milieu 
prevent the development of the toxic insult independently from the 
exposure times to PLTXs (Figure 23 and 24).  
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Figure 23. Toxicity of PLTX on mouse skeletal muscle cells assessed by 
sulforhodamine B assay. Cell survival after 1, 2, or 4 hours of exposure to PLTXs (1 
nM) and recovery up to 24 hours in toxin-free medium. (* p < 0.05 in comparison to 
control; n = 3). 
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Figure 24. Toxicity of PLTX on mouse skeletal muscle cells assessed by 
sulforhodamine B assay. Cell survival after 1 or 2 hours of exposure to PLTXs (1 nM) 
and recovery up to 24 hours in toxin-free medium. (* p < 0.05 in comparison to control; 
n = 3). 
 
4.1.6. Influence of Ca
2+
 on PLTX binding 
 
Binding experiments have been performed to verify the interaction of 
PLTXs with the Na
+
/K
+
 pump in the absence of [Ca
2+
]e. Since 
radioactive PLTXs are not commercially available, an indirect 
approach was applied; [
3
H]-ouabain, was used as radiolabelled ligand 
and experiments were performed to measure the ability of PLTX and 
42-OH-PLTX to displace it.  
First of all, the reversibility of the binding between [
3
H]-ouabain and 
intact skeletal muscle myotubes was verified and the concentration-
dependence relationship was established (Figure 25).  
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Figure 25. [
3
H]-ouabain binding on skeletal muscle cells. CPM detected on skeletal 
muscle cells after 90 minutes of incubation with increasing concentrations of [
3
H]-
ouabain. Data are the mean of 4 independent experiments performed in triplicate ± 
S.E. 
 
The concentration of 15 nM [
3
H]-ouabain was chosen for the 
displacement binding assays.  
The total binding of [
3
H]-ouabain (Figure 26, grey triangles) was 
slightly reduced in presence of Ca
2+
, however the difference was not 
significant.  
In the presence of extracellular Ca
2+
 (control), PLTX started to displace 
[
3
H]-ouabain from the concentration of 3 nM. Increasing the 
concentration of PLTX (10 nM), a significant reduction of the binding 
of [
3
H]-ouabain was observed (mean reduction of about 60 %). On the 
contrary, no significant displacement of [
3
H]-ouabain occurred when 
the same experiment was conducted, adding PLTX in the absence of 
[Ca
2+
]e.  
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Figure 26. PLTX binding on skeletal muscle cells. CPM detected on skeletal muscle 
cells after 90 minutes of incubation with increasing concentrations of PLTX (A) or 
42-OH-PLTX (B), in presence of 15 nM [
3
H]-ouabain.  Data are the mean of 3 (A) 
and 2 (B) independent experiments performed in triplicate ± S.E. (* p <0.05 at the 
Student’s  t-test as compared to  control). 
 
Similarly, the addition of 42-OH-PLTX (1, 3, 10 nM) to the skeletal 
myotubes in presence of [
3
H]-ouabain caused a concentration-
dependent displacement of the tritiated molecule. As previously 
observed for PLTX, in Ca
2+
-free external solution, the ability of 10 nM 
42-OH-PLTX to displace [
3
H]-ouabain was reduced in comparison to 
controls. 
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4.1.7. Contribution of Ca
2+
 stores to the [Ca
2+
]i increase and 
cytotoxicity induced by PLTX 
 
In order to verify the role of intracellular Ca
2+
 stores in the [Ca
2+
]i 
increase triggered by PLTX, videoimaging experiments were performed 
in the presence of 1 µM cyclopiazonic acid (Cyc; Figure 27),  a well-
known blocker of the sarcoplasmic Ca
2+
-ATPase pump (Plenge-
Tellechea et al., 1997). By blocking the pump, cyclopiazonic acid causes 
emptying of the intracellular Ca
2+
 reservoir and abolishes any possible 
contribution of Ca
2+
 release from intracellular stores. Pre-incubation with 
cyclopiazonic acid significantly decreased the amplitude of the transient 
phase of the [Ca
2+
]i increase triggered by PLTX (control 6nM PLTX: 
49.7 ± 4.7 % of [Ca
2+
]i increase versus 6 nM PLTX in Cyc: 7.6 ± 3.7 %), 
but did not decreased the amplitude of the long-lasting phase (n = 12 
cells; Figure 27). 
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Figure 27. Contribution of intracellular Ca
2+
 stores to the [Ca
2+
]i increase elicited by 
PLTX. (A) Representative temporal plots of [Ca
2+
]i  response after addition of 6 nM 
PLTX in control conditions and in the presence of 1 µM Cyc. Trace interruption 
stands for 30 minutes. (B) Effect of depletion of the intracellular Ca
2+
stores on 
amplitude of transient and long-lasting phases of the [Ca
2+
]i increase (* p < 0.05 in 
comparison to 6 nM PLTX; n = 12 cells). 
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4.1.8. Contribution of Ca
2+
 influx to the [Ca
2+
]i increase and 
cytotoxicity triggered by PLTX  
 
Videoimaging experiments were performed in cells bathed in an external 
solution without Ca
2+
 but preserving the ionic strength of it. To do this,  
Ca
2+
 was substituted with equimolar concentration of Mg
2+ 
(Figure 28).  
 
Figure 28. Contribution of extracellular Ca
2+
 influx to the [Ca
2+
]i increase induced by 
PLTX. (A) Representative temporal plots of [Ca
2+
]i measured in mouse skeletal 
muscle cells after addition of PLTX (6 nM) in control and Ca
2+
-free conditions (Ca
2+
 
replaced with Mg
2+
). Trace interruption stands for 30 minutes. (B) Effect of the 
absence of extracellular Ca
2+
 on the amplitude of transient and the long-lasting phases 
of the [Ca
2+
]i increase (* p < 0.05 in comparison to 6 nM PLTX; n = 28 cells). 
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In this experimental condition, the transient phase of the [Ca
2+
]i 
increase was not altered (52.3 ± 4.3% higher than basal [Ca
2+
]i; n = 28 
cells), but the absence of extracellular Ca
2+
 almost abolished the long-
lasting phase, whose amplitude was reduced to 11.9 ± 1.0 % (n = 28 
cells; Figure 28). 
SRB experiments were performed incubating cells with toxin in presence 
of 1 µM Cyc or in Ca
2+
-free solution, following the same protocol 
described for videoimaging experiments (Figure 29). The presence of 
Cyc did not affect the PLTX-induced cytotoxic effect. Interestingly, 
when Ca
2+ 
in the extracellular solution was replaced with Mg
2+
, toxicity 
was completely prevented. This results strongly suggested a correlation 
between the long-lasting phase of the [Ca
2+
]i transient induced by PLTX 
and its toxicity. 
 
 
Figure 29. Contribution of extracellular and intracellular Ca
2+
 to PLTX toxicity. Cell 
survival measured after 30 minutes and 1 hour of incubation with PLTX (1 nM) in 
Ca
2+
-free solution or in presence of 1 µM Cyc, compared to control (* p < 0.05 in 
comparison to 1 nM PLTX). 
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4.1.9. Extracellular Ca
2+ 
influx through voltage-dependent channels 
and Na
+
/Ca
2+
 exchanger  
 
In our experimental model (more than 5 days of differentiation), the 
prevalent class of voltage-dependent Ca
2+
 channels expressed by 
myotubes is the L-type (Luin  et al., 2007). For this reason, we planned to 
study the response of PLTX in the presence of the specific blocker 
verapamil (20 µM) (Flockerzi et al., 1986). Verapamil decreased by 
nearly 60 % the amplitude of the transient phase of the Ca
2+
 response 
elicited by 6 nM PLTX in comparison to controls. However, it did not 
affect the long-lasting phase (n = 34 cells; compare Figure 30A and B; 
Figure 30F). The non selective blockers of the voltage-dependent Ca
2+
 
channels cadmium  (500 µM) and lanthanum  (100 µM) had similar 
effects, inhibiting the transient (n = 12 cells) but not the long-lasting 
phase (n = 12 cells; compare Figure 30A and C; Figure 30F). These 
results ruled out the possibility that voltage-operated Ca
2+
 channels other 
than L-type were involved in the long-lasting phase of the [Ca
2+
]i 
increase. 
To test the role of the Na
+
/Ca
2+
 exchanger, cells were exposed to 6 nM 
PLTX in the presence of 5 µM KB-R7943, which prevents the reverse 
mode of the exchanger (Naro et al., 2003).  
As observed with verapamil, KB-R7943 inhibited the transient phase by 
~ 30 %, (n = 42 cells) and did not alter the sustained phase of PLTX-
induced Ca
2+
 response (Figure 30A and D; Figure 30F ). The long-lasting 
phase of the [Ca
2+
]i increase remained unchanged even when 6 nM PLTX 
was added to the cells in presence of both blockers (n = 46 cells;   Figure 
30A and E; Figure 30F). 
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Figure 30. Contribution of L-type channels and Na
+
/Ca
2+
 exchanger (reverse mode) to 
the [Ca
2+
]i increase induced by PLTX. Representative temporal plots of [Ca
2+
]i after 
addition of PLTX (6 nM) in control conditions (A), in the presence of 20 µM verapamil 
(B; n = 34 cells), 100 µM La
3+
 and 500 µM Cd
2+
 (C; n = 12), 5 µM KB-R7943 (D; n = 
42 cells), or Ver and KB-R7943(E; n = 46 cells). Trace interruption stands for 30 
minutes. (* p < 0.05 in comparison to 6 nM PLTX). 
 
The effect of verapamil and KB-R7943 on [Ca
2+
]i increase induced by 
42-OH-PLTX, was even more limited than for the parent compound 
(Figure 31).  
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Figure 31. Contribution of L-type channels and Na
+
/Ca
2+
 exchanger (reverse mode) to 
the [Ca
2+
]i increase induced by 42-OH-PLTX. Representative temporal plots of [Ca
2+
]i 
after addition of 42-OH-PLTX (6 nM) in control conditions (A), in the presence of 20 
µM verapamil (B; n = 34 cells), 5 µM KB-R7943 (C; n = 42 cells), or Ver and KB-
R7943 (D; n = 46 cells). Trace interruption stands for 30 minutes (* p < 0.05 in 
comparison to 6 nM 42-OH-PLTX). 
 
Verapamil altered neither the amplitude of the transient phase (39.1 ± 5.3 
%; n = 42 cells) nor the delayed and long-lasting increase of the [Ca
2+
]i 
(55.5 ± 3.0 %, n = 42 cells; Figure 31A-B and E). Similar effects were 
also observed after incubation with KB-R7943 (Figure 31A-C and E). 
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The only experimental conditions  able to reduce [Ca
2+
]i increase 
triggered by 42-OH-PLTX was the concomitant addition of the two 
blockers. In this case, the transient phase of the [Ca
2+
]i increase was 
reduced to 26.2 ± 3.7 % (n = 38 cells) and the long-lasting phase to 23.6 
± 1.7 % (n = 38 cells). We have also checked possible beneficial effect of 
verapamil and KB-R7943 in reducing and/or slowing down the 
progression of the cytotoxicity of PLTXs The presence of the blockers 
did not prevent or inhibit the development of the cytotoxic effect induced 
by PLTX and 42-OH-PLTX (Figure 32). 
 
Figure 32. Contribution of L-type channels and Na
+
/Ca
2+
 exchanger (reverse mode) to 
the toxicity of PLTX on mouse skeletal muscle cells. Cell survival after 1 or 2 hours of 
exposure to 1 nM PLTX (black) and 42-OH-PLTX (grey) and recovery up to 24 hours. 
Experiments were performed with toxins alone (full bars), in presence of KB-R7943 
(horizontal bars), verapamil (vertical bars) or both (squared bars)  (* p < 0.05 in 
comparison to control; n = 3). 
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4.1.10. Extracellular Ca
2+ 
influx through voltage-independent Ca
2+
 
channels and its contribution to the cytotoxicity  
 
The contribution of store-operated and stretch-activated channels to the 
Ca
2+
 influx triggered by 6 nM PLTX was investigated using SKF-96365 
or gadolinium (Gd
3+
), widely used as blockers of both voltage-
independent channel types (Molgo et al., 1991; Hamill and McBride, 
1996; Ducret et al., 2006; Formigli et al., 2007; Ducret et al., 2010). 
Videoimaging experiments showed that, in cell preincubated with 20 µM 
SKF-96365 (30 min at 37 °C), the first transient of the Ca
2+
 response 
elicited by PLTX was significantly decreased (by ~ 75 %; 16.1 ± 5.2 % 
of [Ca
2+
]i increase) compared to controls. The long-lasting phase was 
reduced, but the effect of SKF-96365 was not statistically significant (n = 
18; Figure 33).  
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Figure 33. Contribution of store-operated Ca
2+
-channels to the [Ca
2+
]i increase induced 
by PLTX. (A) Representative temporal plots of [Ca
2+
]i after addition of PLTX (6 nM) in 
control conditions or presence of  SKF-96365 20 µM. Trace interruption stands for 30 
minutes. (B) Effect of SKF-96365 on the two phases of the PLTX-induced [Ca
2+
]i 
increase (* p < 0.05 in comparison to 6 nM PLTX; n = 18 cells). 
 
Gd
3+
 did not significantly affect the amplitude of the transient phase of 
the PLTX-induced response (n = 45 cells).  However, Gd
3+ 
markedly 
decreases the long-lasting phase of the [Ca
2+
]i increase (n = 45 cells; 
Figure 34).  
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Figure 34. Contribution of stretch-activated Ca
2+
-channels to the [Ca
2+
]i increase 
induced by PLTX. (A) Representative temporal plot of [Ca
2+
]i after addition of PLTX (6 
nM) in control conditions or presence of 100 µM Gd
3+
. Trace interruption stands for 30 
minutes. (B) Effect of Gd
3+ 
on the two phases of the PLTX-induced [Ca
2+
]i increase (* p 
< 0.05 in comparison to 6 nM PLTX; n = 45 cells). 
 
The washout of Gd
3+
resulted in a restoration of the long-lasting Ca
2+
 
signal induced by PLTX (n = 17 cells; Figure 35).  
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Figure 35. Contribution of stretch-activated Ca
2+
-channels to the [Ca
2+
]i increase 
induced by PLTX. (A) Representative temporal plot of [Ca
2+
]i after addition of PLTX (6 
nM) in control conditions or presence of 100 µM Gd
3+
. Trace interruption represents 
wash necessary for toxin removal. (B) Effect of washout procedure on PLTX-induced 
[Ca
2+
]i increase in control conditions (black bars) and in presence of Gd
3+
 (white bars) (* 
p < 0.05 in comparison to 6 nM PLTX; n = 17 cells). 
 
To confirm the connection between the long-lasting phase of [Ca
2+
]i 
increase triggered by PLTX and toxicity, sulforhodamine B assay was 
performed in the presence of Gd
3+
. Under these conditions, the 
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cytotoxicity of PLTX was significantly reduced with a 30% increase in 
cell survival after 1 h exposure to 1 nM PLTX (Figure 36). 
 
Figure 36. Contribution of stretch-activated Ca
2+
-channels to the toxicity induced by 
PLTX. Cell survival measured after 30 minutes and 1 hour of incubation with PLTX 
(1 nM) in presence of 100 µM Gd
3+
 compared to controls (* p < 0.05 in comparison 
to 1 nM PLTX; n = 4 independent experiments performed in triplicate). 
 
Cytotoxicity test were also performed incubating the cells in the 
presence of 20 µM SKF-96365. No effect was observed (Figure 37). 
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Figure 37. Effect of the broad spectrum Ca
2+
-channels blocker SKF-96365 to the 
toxicity induced by PLTX. Cell survival measured after 30 minutes and 1 hour of 
incubation with PLTX (1 nM) in the presence of 20 µM SKF-96365 compared to 
controls (* p < 0.05 in comparison to 1 nM PLTX, n = 3 independent experiments 
performed in triplicate). 
 
Since the activation of stretch-activated Ca
2+
 channels and the consequent 
[Ca
2+
]i increase seems to play a crucial role in the mechanism of action of 
PLTX, further experiments were performed to deepen their correlation 
with the development of the myotoxic insult. The activation of stretch-
activated Ca
2+
 channels  is known to trigger ROS production in skeletal 
muscle cells and PLTX by itself triggers the production of reactive 
oxygen species in several cell models (Sala et al., 2009; Pelin et al., 
2011). For these reasons it was decided to verify if a radical scavenger 
could prevent, or at least reduce, PLTX-induced damage on skeletal 
muscle cells. With this aim, the well-known antioxidant Trolox was 
tested. The presence of 100 µM Trolox significantly reduced PLTX-
induced toxicity on myotubes during the first 30 min of exposure to the 
toxic insult; the protective effect of trolox decreases within 1 h and was 
completely lost after 2 h (Figure 38).  
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Figure 38. Contribution of  ROS to PLTX  toxicity. Cell survival measured after 30 
minutes, 1 and 2 hours of incubation with PLTX (1 nM) in presence of 100 µM Trolox 
compared to controls (* p < 0.05 in comparison to 1 nM PLTX; n =3 independent 
experiments performed in triplicate). 
 
4.1.11. Contribution of Cl
-
 to  the PLTX-induced toxicity 
 
Since channels and exchangers for Cl
-
 have been related to the 
development of PLTX-induced toxicity (Pérez-Gómez et al., 2010), some 
experiments were carried out to investigate this aspect. We observed that 
the cytotoxic effect of PLTX was dependent on the presence of [Cl
-
]e: the 
absence of the anion in the extracellular solution protected skeletal 
muscle cells from PLTX-induced damage. In more detail, we observed 
that the absence of [Cl
-
]e  prevented the acute damage induced by PLTX 
(Figure 39).  
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Figure 39. Effect of Cl
-
-free solution on PLTX-induced acute toxicity. Cell survival 
measured after 30 min,  1 h and 2 h of incubation with PLTX (1 nM) in the presence or 
in the absence of [Cl
-
]e compared to control (* p < 0.05 in comparison to 1 nM PLTX; n 
= 3 independent experiments performed in triplicate). 
 
The absence of [Cl
-
]e prevented the toxic effects that usually develop 
within 24 h post PLTX application, but only when the incubation with the 
toxin lasted no more than 1 h (Figure 40).  
In parallel, the effect of 1 mM DIDS (4,4'diisothio-cyanatostilbene-2,2'-
disulfonic acid) an inhibitor of Cl
-
 channels, was also studied. Although 
the blocker is among those characterised by wider spectra, it was not as 
efficient as Cl
-
-free conditions in blocking toxicity. However, the cell 
survival in presence of DIDS was significantly higher than in the 
presence of the toxin alone (Figure 40). 
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Figure 40. Effect of Cl
-
-free solution on PLTX-induced delayed toxicity. Cell survival 
measured after 30 min, 1 h and 2 h of incubation with PLTX (1 nM) in the presence or 
in the absence of extracellular Cl
-
 and 1 mM DIDS followed by recovery up to 24 hours, 
compared to control (* p < 0.05 in comparison to 1 nM PLTX; n = 3 independent 
experiments performed in triplicate). 
 
Videoimaging experiments were then performed to evaluate the effect of 
Cl
-
-free conditions on PLTX- induced [Ca
2+
]i transients (Figure 41).  
In Cl
-
-free conditions, the toxin was still able to cause an increase of the 
[Ca
2+
]i , however the amplitude of the transient phase (42.6 ± 6.0 % of 
[Ca
2+
]i increase, n = 10 cells) and of the long lasting phase (69.6 ± 5.0 %) 
appeared reduced (Figure 41). 
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Figure 41. Effect of Cl
-
-free conditions on the [Ca
2+
]i increase induced by PLTX. (A) 
Representative temporal plots of [Ca
2+
]i measured in mouse skeletal muscle cells after 
addition of PLTX (6 nM) in control and Cl
-
-free conditions. Trace interruption stands 
for 30 minutes. (B) Effect of the absence of extracellular Cl
- 
on the amplitude of 
thetransient and the long-lasting phases of the [Ca
2+
]i increase (* p < 0.05 in comparison 
to 6 nM PLTX; n = 10 cells). 
 
To further analyse the role of Cl
-
 ions, the activation of Ca
2+
-activated Cl
-
 
channels was also investigated. To this aim a derivative of niflumic acid 
was used (Figure 42).  
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Figure 42. Contribution of Ca
2+
-dependent Cl
- 
channels to PLTX-induced toxicity. Cell 
survival measured after 30 min and 1 h of incubation with PLTX (1 nM; black bars) in 
presence or absence of Talniflumate 50 and 100 µM (white and grey bars, respectively) 
(* p < 0.05 in comparison to 1 nM PLTX; n = 3 independent experiments performed in 
triplicate). 
 
Results excluded any significant role of Ca
2+
-dependent Cl
-
 channels in 
the cytotoxicity induced by PLTX.  
 
4.1.12. Structure activity relationship: PLTX-analogue OST-D 
 
To further investigate the correlation between structural variation of 
PLTXs and biological responses of skeletal muscle cells in relation to 
toxicity, additional experiments were performed with OST-D. 
Videoimaging experiments revealed that OST-D triggers an [Ca
2+
]i 
increase different from that triggered by commercial PLTX (Figure 43). 
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Figure 43. Effect of PLTX and OST-D on the [Ca
2+
]i of mouse skeletal muscle cells. (A) 
Representative temporal plots of [Ca
2+
]i after addition of PLTX (6 nM) or OST-D (6 
nM). (B) Quantification of toxins-induced [Ca
2+
]i increase: PLTX (black bars) and OST-
D (white bars) (* p < 0.05 in comparison to 6 nM PLTX; n = 40 cells). 
 
In more detail, the transient phase of [Ca
2+
]i increase was comparable in 
cells stimulated with the two toxins (6 nM PLTX, 77.3 ± 4.8 % versus 
OST-D, 65.0 ± 5.4 % of [Ca
2+
]i increase). On the contrary, in cells 
stimulated with the analogue, the second long lasting phase of the [Ca
2+
]i 
increase was completely abolished.  
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Cytotoxicity was measured after 24 hours of incubation with OST-.D 
(concentration range from 0.004 to 9 nM), following the same 
experimental protocol used to assess cytotoxicity of PLTX and 42-OH-
PLTX (Figures 7A and 8A). The EC50 for OST-D was 2.5 ± 0.05 nM, 
thus five times higher than the parent compound. Thus, OST-D resulted 
less cytotoxic than parent compound. 
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4.2. In vivo studies 
To characterize the effects of oral intake of PLTX, as possible seafood 
contaminant, a sub-acute toxicity study was performed in mice. Groups 
of 6 mice were daily administered with the toxin (30, 90, 180 
µg/kg/die) for 7 days, and observed up to 24 h (3 mice) or 14 days (3 
mice) after the last treatment. 
 
4.2.1. Lethality 
 
Daily repeated oral administration of PLTX for 7 days (30, 90, 180 
µg/kg/day) caused mortality at all the doses tested. Up to 24 hours after 
the last treatment, lethality was observed in a dose-dependent manner 
(Figure 44A). 
In fact, 2/6 mice treated with 30 µg PLTX/kg, 2/6 mice treated with 90 
µg/kg and 5/6 mice with 180 µg/kg died during the observation period.  
Analysis of lethality versus time (Figure 44B), revealed that mortality 
started after the 3
rd
 day of treatment. 
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Figure 44. Lethality recorded during the first 8 days of treatment. Dose-dependent 
lethality (A). Time-dependent lethality (B). 
 
4.2.2. Symptoms 
 
Animals that died during the treatment presented several signs and 
symptoms involving both the gastrointestinal apparatus and other 
systemic targets, possibly the central nervous system. 
One of the most peculiar signs observed during the p.o. administration 
of PLTX was swelling of the abdominal cavity. In particular, this sign 
was recorded from the 3
rd
 day of toxin administration (30 µg/kg) in 4/6 
animals and also in 3/6 animals treated with 90 µg/kg. At the dose of 
180 µg/kg, abdominal swelling was recorded just in 1/6 mice that died 
during the observation period. 
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In general, immediately before death, loss of coordination and hypo-
reactivity were observed. General sedation, persistent also after mild 
stimulation, was associated to loss of the righting reflex and, in the 
worst cases, to paralysis of the hind limbs.  
Breathing difficulties and gasping were also observed in some cases 
prior to death, indicating severe impairment of respiratory function. 
Even if the mortality was lower in mice treated with 30 and 90 µg/kg 
with respect to the highest administered dose, signs of general malaise 
during the period of toxin administration were also recorded. In 
particular, presence of chromodacryorrhoea (visible as a red secretion 
around the eyes) was visible in 2/6 and 1/6 animals treated with PLTX 
at 30 and 90 µg/kg, respectively. 
 
4.2.3. Body weight 
 
During the whole study, body weight of the animals was monitored 
daily. All the animals underwent prominent decrease of body weight 
prior to death (Figure 45).  
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Figure 45. Body weight recorded during toxin administration in the four groups of 
treatment. Trace interruption corresponds to animal death. A. Control. B. 30 µg/kg. C. 
90  µg/kg. D. 180  µg/kg. 
 
4.2.4. Necroscopic examination 
 
Necroscopic examination was performed on all animals of the study. 
Animals that presented swelling at the abdomen were found to have 
massive liquid accumulation in the intestinal tract. Stomach and both 
small and large intestine were characterized by decreased content of 
digested feed and organs wall were tensed from swelling (Figure 46B 
and C) in comparison to control (Figure 46A). 
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Figure 46. Appearance of the abdominal cavity of mice during necroscopic 
examination. A. Control. B. 30  µg/kg. C. 90  µg/kg.. 
 
Moreover, in 1/6 of the mice treated with the dose of 180 µg/kg, areas 
of discoloration, compatible with necrosis were observed in the liver 
(Figure 47). 
 
 
Figure 47. Appearance of the liver during necroscopic examination. Arrow indicates 
discoloration compatible with necrosis (dose: 180 µg/kg ). 
 
4.2.5. Recovery 
 
At the end of toxin administration, 3 animals from each group of 
treatment were kept alive for a recovery study of 14 days; for the group 
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treated with 180 µg PLTX/kg, the recovery study was performed on the 
only survived animal.  
During recovery period we observed mortality in 1/3 and 2/3 animals 
that had been treated with 30 and 90 µg/kg, respectively. As previously 
described, during the recovery a marked decrease in body weight was 
recorded in mice that died within the end of the recovery period (Figure 
48). 
 
Figure 48. Body weight recorded during the whole study in four groups of treatment. 
Trace interruption corresponds to animal death. A. Control. B. 30  µg/kg. C. 90  
µg/kg. D. 180  µg/kg.. 
 
4.2.6. Histological analysis 
 
Although no specific cause of death was found in dead mice, multi-
organ alterations were observed microscopically in mice that died 
113 
 
during the treatment and recovery period, throughout the dosed groups, 
which are most likely linked to treatment. 
In the lungs,  alveolar  edema slight to severe in degree, in some cases 
associated to acute inflammation (Figure 50) and necrosis (Figure 51), 
was observed in 2/6 animals treated at the dose of 30 µg/kg, 2/6 treated 
at 90 µg/kg and 2/6 treated at 180 µg/kg. No alterations were recorded 
in control animals (Figure 49).  
 
 
Figure 49. Lungs. Representative histological section of the lung from a control 
mouse. Scale bar stands for 50 µm.  
114 
 
 
 
 
Figure 50. Lungs. Representative histological sections of acute inflammation in 
PLTX treated animals. A. 30  µg/kg; B. 90  µg/kg; C. 30  µg/kg. Scale bars stand for 
50 µm. 
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Figure 51. Lungs. Representative histological section of necrotic area (dose 30 
µg/kg) . Scale bar stands for 50 µm.  
 
At the hepatic level, it was observed a depletion of the glycogen 
content in the hepatocytes, visible as more a consistent structure of the 
hepatic cells (Figure 52 and 53).   
 
 
Figure 52. Liver. Representative histological section of the liver from a control 
mouse. Scale bar stands for 50 µm.  
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Figure 53. Liver. Representative histological sections of glycogen depletion in PLTX 
treated animals. A. 30  µg/kg; B. 90  µg/kg;  C. 30  µg/kg. Scale bars stand for 50 µm. 
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Various degrees of glycogen depletion were noted among the doses 
groups without relationship (Figure 53). In the liver of 1/6 animals 
treated with 180 µg/kg of PLTX, focal foci of hepatic necrosis were 
observed (Figure 54). 
 
 
Figure 54. Liver. Representative histological section of necrotic area (dose 180 
µg/kg). Scale bar stands for 50 µm.  
 
In one animal treated with 30 µg PLTX/kg it was also possible to 
identify the presence of mild gastric ulcers, even if they were limited to 
the non-glandular stomach.    
At cardiac level some fibers presented hyper-eosinophylia with 
incidence of 2/6  in mice treated  at 30 µg/kg, 1/6 treated at 90 µg/kg 
and 5/5  at 180 µg/kg (Figure 55 and 56).   
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Figure 55. Cardiac muscle. Representative histological section of the heart from a 
control mouse. Scale bar stands for 50 µm.  
 
Moreover, in some areas of the cardiac muscle from animals treated 
with the dose of 180 µg/kg, concomitant  degenerative process, notable 
as cytoplasm vacuolization was also noted (Figure 56C, full arrows). 
Slight edema of the cardiac muscle, observed as separation of the 
muscle fibres was also recorded in the same animals treated with the 
highest dose of toxin  (Figure 56B and C, empty arrows).   
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Figure 56. Cardiac muscle. Representative histological sections of muscular damage 
in PLTX treated animals. A. 30  µg/kg; B. 90  µg/kg;  C. 30  µg/kg. Scale bars stand 
for 50 µm. 
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Increased cellularity between fibers was noted in skeletal muscle  from 
2/3 and 4/4 mice that died during the study, after the treatment with the 
toxin at 30 µg/kg and 90 µg/kg, respectively (Figure 57 and 58). 
 
 
Figure 57. Skeletal muscle. Representative histological section from the skeletal 
muscle of a control mouse. Scale bar stands for 50 µm.  
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Figure 58. Skeletal muscle. Representative histological sections of muscular 
alterations in PLTX treated animals. A. 30  µg/kg; B. 90  µg/kg;  C. 30  µg/kg. Scale 
bars stand for 50 µm. 
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Histological analysis of the kidneys of treated animals revealed 
presence of erythrocytes in several areas of the tubuli and of Bowman’s 
capsules in comparison to control (Figure 59 and 60). Incidence of this 
observation was 3/6  in animals that were treated with 30 µg PLTX/kg, 
4/6 in animals treated at 90 µg/kg and 1/6 at the dose of 180 µg/kg. At 
the highest dose some degree of tubular dilatation and congestion was 
also observed (Figure 60C). 
 
 
Figure 59. Kidney. Representative histological section of a kidney from a control 
mouse. Scale bar stands for 50 µm.  
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Figure 60. Kidney. Representative histological sections of renal alterations in PLTX 
treated animals. A. 30  µg/kg; B. 90  µg/kg;  C. 30  µg/kg. Scale bars stand for 50 µm. 
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In comparison to controls, in the spleen of the animals treated with two 
lower doses (30 and 90 µg/kg), a moderate depletion of the lymphoid 
elements of the lymphatic follicles was observed (Figure 61 and 62). 
The finding was not consistent and not dose-dependent since it was not 
observed at the highest dose.  
Animals that were sacrificed at the scheduled time-points did not 
present any of the above mentioned histological alterations in organs 
observed related to the administration of the toxin. 
 
 
Figure 61. Spleen. Representative histological section of the spleen from a control 
mouse (arrow: lymphoid elements). Scale bar stands for 100 µm.  
 
 
125 
 
 
 
 
Figure 62. Spleen. Representative histological sections of spleen alterations in PLTX 
treated animals. A. 30  µg/kg; B. 90  µg/kg;  C. 30  µg/kg (arrow: lymphoid 
elements). Scale bars stand for 50 µm. 
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5. DISCUSSION 
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5.1. In vitro studies 
 
One of the goals of the PhD project was to investigate the effect of 
PLTXs on primary culture on mouse skeletal muscle cells, a predictive in 
vitro model for the study of the mode of action of PLTXs on skeletal 
muscle tissue, one of their primary toxicological targets. To this aim, at 
first the experiments were performed in parallel with PLTX and 42-OH-
PLTX to provide, not only toxicological data on the muscular toxicity of 
these compounds, but also to highlight the potential differences between 
the parent (commercial) compound and its analogue (unfortunately 
available only in very limited quantities). Once assessed the similar 
behaviour of the two toxins in terms of ability to trigger [Ca
2+
]i increase, 
cytotoxic effects, binding properties, the further experiments for a 
detailed elucidation of the mechanism of action were limited to the parent 
compound. However, once identified the crucial steps for the 
development of the cytotoxicity, to give a more complete overview of the 
effects of this family of toxins on skeletal muscle, selected experiments 
with OST-D were also performed. 
The first finding of the present work is that PLTXs reduce the viability of 
differentiated skeletal muscle cells with an EC50 of 0.54 and 0.36 nM 
after 24 h of continuous incubation with PLTX and 42-OH-PLTX, 
respectively (SRB assay). These values are in agreement with recent 
reports for the potency of this family of compounds on excitable cells 
(Pérez-Gómez et al., 2010). In addition, PLTXs significantly reduced cell 
survival, indicating that limited exposures to these toxins are sufficient to 
trigger irreversible toxic effects on skeletal muscles. Also the observation 
that PLTXs induce persistent toxic effects on skeletal muscle cells even 
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after exposures as short as 1-4 hours finds support in literature. Indeed, 
experiments performed on HaCaT (Pelin et al., 2011) and Caco-2 cells 
(Pelin et al., 2012) cells revealed that incubation with PLTX induces a 
cellular damage that develops even after the removal of the toxic stimulus 
from the culture medium. Moreover, from the functional point of view, it 
was also observed that the toxin triggers an irreversible contraction of 
frog heart muscle (Sauviat, 1989) and in smooth muscle (Ito et al., 1977).  
We have also observed that exposure of differentiated skeletal muscle 
cells to both PLTX and 42-OH-PLTX, in the nanomolar range, induced 
morphological changes, as rounding and formation of vacuoles within 
cells. Similar observation were reported also by Sheridan and co-workers 
in smooth muscles (Sheridan et al., 2005), suggesting that, independently 
from muscle type, the toxins induce a defined degeneration pathway in 
this type of tissue. AFM microscopy confirmed the effects of PLTX at 
morphological level showing a clear progression of the skeletal muscle 
cell damage with prominent membrane swelling.  It is worth noticing 
that, even if recent experiments have reported no effects of PLTX on the 
morphology and mechanical properties of breast cancer MCF-7 cells, 
these experiments have been performed at a concentration 20 times lower 
than that used in the present study (Prandi et al., 2011). Using AFM 
microscopy, we have also observed loss of cell adhesion recordable as 
cellular shifts associated to the movement of the cantilever. Ionic 
unbalance caused by PLTX is likely to play a prominent role in the 
skeletal muscle cell detachment, as reported in other non-muscular 
cellular models such as neuroblastoma cells (Louzao et al., 2007; 
Valverde et al., 2008). 
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In our experimental conditions, primary skeletal mouse myotubes express 
ACh receptors (Bandi et al., 2005). As at the neuromuscular junction 
level in vivo, binding of ACh to the receptors causes membrane 
depolarization and activation of excitation-contraction cascade. The latter 
begins with the activation of L-type voltage-dependent Ca
2+
 channels 
coupled with ryanodine receptors and [Ca
2+
]i increase and ends with 
mechanical contraction of the muscle cell. In light of this, responsivity to 
the neurotransmitter acetylcholine (ACh) has been chosen as index of the 
functionality of skeletal muscle cells exposed to PLTXs, and Ca
2+
 
imaging has been used to assess it. The decreased sensitivity to the 
physiological neurotransmitter ACh observed in myotubes after exposure 
to PLTXs could be the result of several effects of the toxins. For 
example, PLTX was already known to impair the excitation-contraction 
coupling of cultured atrial myocytes (Kockskämper et al., 2004). 
However, independently from the specific mechanism, our observation 
suggests that the toxin can impair crucial functional properties of 
excitable cells long before inducing cellular death.  
The effect of PLTX and 42-OH-PLTX by staining for desmin, an 
intermediate filament of cytoskeleton, has been presented here for the 
first time. Even if PLTX and its analogue OST-D are known to induce 
disorganization of actin cytoskeleton in several excitable and non-
excitable cell models  (Louzao et al., 2011), the effects of the toxins on 
the intermediate filaments of skeletal muscle have never been reported so 
far. Intermediated filaments represent not only major structural and 
scaffold proteins of skeletal muscle cells, but they also regulates the 
position of the cellular organelles and vesicles (Capetanaki et al., 2007). 
Thus impairment at this level may result into a severe functional damage 
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for the cell. Even if more stable than other cytoskeletal elements, desmin 
filaments are sensitive to [Ca
2+
]i variations being degraded from Ca
2+
-
dependent proteases (Traub and Nelson, 1981). Considering the [Ca
2+
]i. 
increase induced by PLTXs in our cell model, it is very likely that the 
morphological alteration could be the result of desmin disorganization.  
Videoimaging experiments carried out at high time resolution (1 ratio 
image/s), for up to 30 min after toxin exposure, revealed that both PLTX 
and 42-OH-PLTX triggered a peculiar biphasic [Ca
2+
]i increase in the 
skeletal muscle cells. A first short-lasting increase of the [Ca
2+
]i 
(“transient phase”) was followed by a second persistent [Ca2+]i increase, 
which remained stable up to 30 min after toxin exposure (“long-lasting 
phase”). PLTX has been reported to induce an increase of the [Ca
2+
]i 
increase even before the structural elucidation of the molecule (Rayner et 
al., 1975; Ito et al.,1977); later, the observation has been confirmed with 
purified compound (Ishii et al., 1997; Amano et al., 1997; Vale et al., 
2006). In addition, it has been already demonstrated that Ca
2+
 plays a 
crucial role in the mechanism of action of PLTXs in muscle tissue (Ito et 
al., 1976; Ishii et al., 1997; Bellocci et al., 2011). Here, for the first time, 
a correlation between the long-lasting phase of the [Ca
2+
]i increase 
induced by PLTXs and their toxicity is described.  
In accordance with most quoted mechanism of action on Na
+
/K
+
 pump 
and in line with previous reports (Ecault and Sauviat, 1991; Kinoshita et 
al., 1991), we observed that exposure of skeletal myotubes to PLTXs in 
an extracellular Na
+
-free solution prevented [Ca
2+
]i. increase, as well as 
cytotoxicity (Sheridan et al., 2005). However, the presence of TTX only 
partially reduced the transient phase of the [Ca
2+
]i. increase induced by 
PLTX and 42-hydroxyl-derivative. As previously observed for ouabain 
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(Ciminiello et al., 2009), the effect of 42-OH-PLTX appeared less 
sensitive to the presence of the blocker than PLTX, confirming that even 
if the mechanism of action of the two toxins includes the activation of 
voltage-dependent Na
+
 channels, it is somehow different.  
The inhibition of PLTXs effects in Ca
2+
-free conditions seems to be 
much more complicated to explain. In our experimental model, 
experiments were performed according to two different protocols: in the 
first set of experiments the Ca
2+
 chelator EGTA (5 mM) was added to the 
extracellular solution, in the second, Ca
2+ 
was substituted with equimolar 
concentrations of Mg
2+
. In the first case, the effect of the toxin on [Ca
2+
]i 
increase was completely abolished whereas, in the second, the effect was 
visible as inhibition limited to the long-lasting phase. Binding 
experiments, performed in presence of 5 mM EGTA, revealed a 
significant decrease of the ability of PLTXs to displace 
3
H-ouabain only 
at the higher concentration tested (10 nM). On the contrary, binding 
affinity of PLTXs at lower concentrations was not significantly altered by 
the absence of [Ca
2+
]e. Moreover, binding of ouabain per se seemed to 
be, in some extent sensitive to the presence of extracellular Ca
2+
 making 
the results obtained in the presence of chelator more difficult to interpret 
and possibly biased by an effect of free-Ca
2+
 condition on the binding of 
PLTXs to the Na
+
/K
+
 pump (Ecault and Sauviat, 1991; Kudo and 
Shibata, 1980). Very recent data show that PLTXs have high affinity for 
divalent cations (Ciminiello et al., 2012b). In this light and taking into 
account our results, it could be hypothesised that the cations are required 
to stabilize a conformation of PLTXs with high affinity for the molecular 
targets. 
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Results of the experiments carried out in the presence of Mg
2+ 
are more 
reliable and helpful in the comprehension of the mechanism of action of 
the PLTX. Taking into account that in such experimental condition any 
contribution of Ca
2+
 influx from extracellular compartment was 
prevented, the persistence of the transient phase strongly suggested that 
origin of it in the release of Ca
2+
 from intracellular compartments. In 
addition, and more interestingly, the absence of cytotoxicity when Ca
2+ 
was replaced with Mg
2+
 indicated the long-lasting phase of the [Ca
2+
]i as 
the one responsible for the development of the irreversible cell damage. 
In fact, in the presence of Mg
2+
, the absence of cytotoxicity cannot be 
ascribed to the altered binding of PLTX because: i) replacing Ca
2+
 with 
Mg
2+
 maintains the ionic strength of the milieu (Habermann 1983); and 
ii) the role of Ca
2+
 as cofactor for the PLTX binding to its molecular 
target is guaranteed by the other divalent ion, as already described by 
other authors
 
(Ecault and Sauviat 1991; Kudo and Shibata 1980).  
The effect of the depletion of the intracellular stores on the PLTX-
induced response confirmed that the transient phase (affected by 
cyclopiazonic acid) is mainly sustained by intracellular stores and that the 
long-lasting phase (unaffected) is responsible for the toxic effect.  
 
According to the accepted molecular mechanism of action of PLTX in 
excitable cells, the interaction of the toxin with the Na
+
/K
+
 pump and the 
consequent massive influx of Na
+
 and membrane depolarisation cause 
opening of the voltage-dependent channels and activation of the reverse 
mode of the Na
+
/Ca
2+
-exchanger (Rossini and Bigiani 2011; Frelin and 
Van Renterghem 1995). In view of this, the contribution of voltage-
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dependent Ca
2+
 channels and Na
+
/Ca
2+
-exchanger in PLTX-induced 
biphasic [Ca
2+
]i increase was evaluated in skeletal muscle cells.  
Blockers of voltage-dependent Ca
2+
 channels (verapamil, cadmium and 
lanthanum) and the reverse mode of the Na
+
/Ca
2+
-exchanger (KB-
R7943), even combined, inhibited only the transient phase of the PLTX-
induced Ca
2+
 response. The transient [Ca
2+
]i increase triggered by the 42-
OH-PLTX resulted to be even less sensitive to verapamil and KB-R7943, 
being partially decreased just by the two blockers were applied together. 
In addition, verapamil and KB-R7943 did not protect skeletal muscle 
cells from the toxic insult of PLTX. These results ruled out any 
contribution of voltage-dependent Ca
2+
 channels and Na
+
/Ca
2+
-exchanger 
to the long-lasting increase of [Ca
2+
] and to myotoxic effect induced by 
PLTX. The lack of protective effect of verapamil in skeletal muscle cells 
was in agreement with the results obtained in other excitable cells (Ozaki 
et al., 1983; Sheridan et al., 2005; Pérez-Gómez et al., 2010).  
Since the mechanism sustaining the PLTX-induced [Ca
2+
]i increase is 
still considered “uncertain” (Bellocci et al., 2011), the possibility that the 
long-lasting phase could be based on voltage-independent channels was 
considered. At first, the possible role of store-operated channels was 
explored. Since SKF-96365 did not affect the long-lasting phase elicited 
by PLTX, and did not prevented cytotoxicity, our data excluded any 
significant role for those channels in skeletal muscle cells.  
Because of the morphological alterations and cell swelling induced by 
PLTX in our model and observed by others (Louzao et al., 2011; Rossini 
and Bigiani 2011; Prandi et al., 2011), we also explored the involvement  
of stretch-activated Ca
2+
 channels. Gd
3+
 abolished the long-lasting phase 
of the [Ca
2+
]i increase induced by PLTX, thus suggesting a possible role 
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for stretch-activated channels in the mechanism of action of the toxin. It 
is worth noticing that Gd
3+
, as trivalent cation of the family of 
lanthanides, is also known to inhibit voltage-dependent Ca
2+
 conductance 
in neural cells (Mlinar and Enyard 1993). In our cell system, voltage-
dependent Ca
2+
 blockade seems unlikely. In fact, even at the 
concentration of 100 µM, in the range of those commonly used to 
investigate stretch-activated channels activity (Molgo et al., 1991; Ducret 
et al., 2010), Gd
3+
 did not affect the transient phase as verapamil and 
La
3+
/Cd
2+ 
did.  
Beside the reversible inhibition of the long-lasting phase, Gd
3+
 also 
significantly reduced, although not completely, the toxic effects of PLTX 
on skeletal muscle cells, confirming a crucial role for the stretch-
activated channels in the cascade of events that culminate in cell death.  
Interestingly, the activation of stretch-activated Ca
2+
 channels triggered 
by PLTX could be at the basis of the verapamil-insensitive long-lasting 
(up to 40 minutes) contraction observed in smooth muscle (Ozaki et al., 
1983) as well as of the development of symptoms associated with PLTX 
intoxication, such as muscular spasms and myalgia in humans (Tubaro et 
al., 2011a) and hind limb paralysis in mice (Sosa et al., 2009; Tubaro et 
al., 2011b). This novel aspect of the mechanism of action of PLTX 
represents an intriguing starting point for the further investigation of 
PLTX effects in vivo. 
Osmotic stress associated to mechanical stretch of skeletal muscle is 
known to induce ROS production (Martins et al., 2008), that is supposed 
to sustain reciprocally Ca
2+ 
signalling (Shkryl et al., 2009). Moreover, 
PLTX itself is known to induce ROS production in human keratinocytes 
(Pelin et al., 2011) and to induce stress response proteins (Sala et al., 
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2009). Since the presence of the radical scavenger Trolox (Jaradat et al., 
2006) significantly reduced PLTX-induced toxicity in our cell model, it is 
likely that the production of ROS could be one of the cellular events that 
follow the influx of Ca
2+
 and that contribute to the toxin insult in the 
skeletal muscle tissue. It is worth noticing that the protective effect of 
Trolox did not last longer than 1 hour. This observation suggests that 
ROS production is an early event and does not exclude that a non-
oxidative damage may follow (Sagara et al., 2011).  
The possible role of Cl
-
 channels was also taken into account. 
Substitution of the extracellular anion was as effective as the absence of 
[Na
+
]e in preventing the development of the myotoxic damage after 
incubation with PLTX. In agreement with a possible role for Cl
-
 
channels, the blocker DIDS partially protected cells from PLTX (see also 
Pérez-Gómez et al., 2010). Interestingly, both phases of PLTX-induced 
[Ca
2+
]i increase appeared reduced in Cl
-
-free solution. To test the possible 
relationship between [Ca
2+
]i and Cl
-
 influx into the cells after incubation 
with PLTX, a set of experiments were performed to check the possible 
role of Ca
2+
-dependent Cl
-
 channels. In the presence of the specific 
blocker talniflumate (Walker et al., 2006), the toxicity induced by PLTXs 
did not change and this exclude a significant role for Ca
2+
-dependent Cl
-
 
conductances. Thus, the specific mechanisms by which Cl
- 
channels 
and/or transporters contribute to the toxicity induced by PLTX in skeletal 
muscle cells remain to be elucidated. 
We have also observed that the [Ca
2+
]i increase induced by the 
analogue OST-D in skeletal muscle cells was less than 1/6
th
 of that 
triggered by parent PLTX. As expected OST-D was also less cytotoxic 
than PLTX, being the  EC50 after 24 hours of continuous incubation 5 
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times lower than that of commercial PLTX. This result is in agreement 
with those of Bellocci and co-workers (2008), which found the 
analogue one order of magnitude less cytotoxic than parent PLTX on 
MCF-7 cells. This data, on the whole suggest that even slight 
modifications of the structure of the molecule, especially those between 
C1 and C44, may have a considerable influence on the biological 
effects of this family of toxins also in the skeletal muscle tissue.   
 
5.2. In vivo studies 
 
PLTX and analogues are considered dangerous seafood contaminants 
and their potential accumulation through the food web suggests that 
their presence may occur in several edible species of fish, shellfish and 
echinoderms (Gleibs and Mebs, 1999; Aligizaki et al., 2008; Aligizaki 
et al., 2011; Tubaro et al., 2011a). Due to the potential wide distribution 
of PLTX and analogues, exposure assessment should consider that 
people can come into contact with the toxin several times within a 
week. Moreover, personal habit must also be taken into account. In this 
respect, a recent survey of EFSA (EFSA, 2010), aimed to the 
definition, at European level, of mean consumption values of shellfish 
for regulatory purposes, considered for Italy maximum shellfish 
consumption up to 4 times/week. The plausibility of a repeated 
exposure to this family of toxins becomes stronger, if we consider the 
delayed occurrence of the symptoms recorded in the study. Obviously, 
intoxications characterized by a short latency period in the onset of 
symptoms, such as, for instance, DSP (Diarrheic Shellfish Poisoning) 
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represent a self-limiting factor for repeated consumption of 
contaminated seafood. 
According to the obtained results, lethality occurred only after the 3
rd
 
day of treatment. This result suggests a certain degree of accumulation 
of the toxin, and/or its toxic metabolites, before appearance of the 
toxicity. Alternatively, the occurrence of a cumulative damage is also 
possible. In the latter case, the repeated effect on target tissues may 
become evident only after reaching a certain threshold. The hypothesis 
that the toxin and/or its metabolites may cause a damage, persistent 
also after the end of the treatment, is supported also by the occurrence 
of lethality during the recovery period. Lethality during recovery period 
has never been observed during acute oral toxicity studies, performed 
in our laboratories with the same mouse strain and similar experimental 
protocol (Sosa et al., 2009; Tubaro et al., 2011), even if the doses were 
considerably higher (from 300 to 1676 µg/kg). The death of 3/6 
animals treated at the dose of 30 µg/kg occurred at a value that is one 
order of magnitude lower than that proposed as LOAEL (Lowest 
Observed Adverse Effect Level) by Ito and Yasumoto after acute 
exposure (Ito and Yasumoto, 2009) and currently used by EFSA for 
regulatory purposes. 
During the period of treatment and also during recovery, general 
malaise of animals was evident as reduced food consumption and 
marked decrease of body weight. Congestions and swelling of the 
gastro-intestinal apparatus, observed during the necropsies, were with 
high probability correlated with this phenomenon. Another sign related 
to general malaise and worsening of the animals condition was 
probably the chromodacryorrhoea.  
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During the experiment of repeated oral toxicity sever damage of the 
gastro-intestinal apparatus was observed. During the necroscopic 
examination intestinal cavity were swollen and occasionally filled with 
fluids. Slight injuries of stomach and small intestine have been 
previously observed also after acute oral administration of PLTX (500 
µg/kg; Ito and Yasumoto, 2009), whereas more severe involvement 
small intestine, with bleeding and congestion was described after intra-
peritoneal (i.p.) administration (Ito et al.,1996). Later after treatment 
(16, 24 hours post-injection; 1 µg/kg), Ito and co-workers also 
described the duodenum to become yellowish and the small intestine to 
become dilated with a large volume of fluid. These later findings 
present strong similarities with the data presented in this thesis, 
suggesting that the peculiar swelling of these abdominal organs could 
be a phenomenon with slow onset. If we consider similarities despite 
the different exposure route, it is possible to hypothesize that these 
signs could be peculiar of PLTX-intoxication. Data describing the 
involvement of intestinal tract after ingestion of PLTX are in good 
agreement also with those reported in literature, after the intoxication 
with PLTX-contaminated seafood. The examination of the intestinal 
apparatus was rarely performed, but in 1988 Tan and Lee reported a 
case of intoxication ascribed to PLTX after ingestion of crabs 
(Lophozozimus pictor). Among post mortem pathological finding, small 
and proximal large intestine filled with bloodstained fluid, severe 
congestion of mucosal lining with areas of hemorrhage were found 
(Tan and Lee, 1988).  
In spite of the appearance of the stomach and intestine at the necropsy, 
histological analysis revealed erosions just in the non-glandular portion 
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of the stomach of one the mice treated with the dose of 30 µg/kg. 
Similar damage was observed more often after acute oral 
administration of the toxin and of its analogue 42-OH-PLTX (Sosa et 
al., 2009; Tubaro et al., 2011), suggesting that high turnover of the 
gastro-intestinal epithelium and limited doses of toxin could hinder the 
development of inflammatory damage. 
In spite of the absence of sites of damage at intestinal level, it is also 
possible that, as a consequence of the swelling and tension of the 
intestine, the paracellular absorption of the biotoxin, and/or its 
metabolites, could have been eased. All the data collected in the study, 
on the whole, suggest that absorption of the toxin takes place, despite 
its polar nature. Paralysis of the hind limbs and breathing difficulties 
were common symptoms of palytoxin treated animals (Munday, 2011), 
that were recorded both after i.p. (Ito et al., 1996; Riobò et al., 2008b) 
and oral administration (Munday 2008; Sosa et al., 2009; Tubaro et al., 
2011b).  
Histological analysis of main tissues and organs, revealed some 
interesting elements. Inflammatory and necrotic damage at pulmonary 
level seems to account for severe breathing difficulties observed in 
animals prior to death. Lung damage, as easily predictable, was 
previously described also after intra-tracheal installation of PLTX and 
after oral and sublingual administration of the toxin; in particular in the 
latter case, interstitial inflammation, bleeding, edema and alveolar 
destruction were observed (Ito and Yasumoto, 2009). The extreme 
sensitivity of lung to the toxin may be at the basis of the respiratory 
problems related to the inhalational exposure to marine aerosol during 
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proliferation of O. ovata (Gallitelli et al., 2005; Durando et al., 2007; 
Kermarec et al., 2008; Tubaro et al., 2011a). 
Depletion of glycogen from hepatocytes was observed also in previous 
studies performed in our facilities to investigate the acute effects of oral 
administration of PLTXs in mice (Sosa et al., 2009; Tubaro et al., 
2011b). This alteration is likely related to the reduction of body weight 
that animals underwent prior to death and to the general worsening of 
their conditions. 
In the present thesis, alterations of cardiac muscle structure were 
observed, visible as fiber separation and cellular vacuolization (mainly 
at 180 µg/kg). Severe involvement of cardiac muscle was previously 
observed also by Terao et al. (1992) after acute i.p. administration of 
the toxin (2 µg/kg). In fact, myofibrillar separation and single cell 
necrosis, together with rounding of mitochondria were found (Terao et 
al., 1992). Vacuolization recalls the degenerative process that muscular 
cells undergoes after incubation with the toxin as shown in the present 
thesis, as well as in smooth muscle cells (Sheridan et al., 2005). It is 
difficult to discriminate if the effects of PLTX at cardiac level are the 
consequence of the direct or secondary effect of the toxin on this tissue. 
In fact, no kinetic data are available for the description of the ADME 
(Absorption Distribution Metabolism and Elimination) of the toxin. Till 
now PLTX effects on the cardiovascular apparatus have been 
investigated in several animal models, even if the majority of the 
studies were carried out with semi-purified toxin. The toxin (semi-
purified 3300 Da m.w.) had direct effects on heart function inducing 
ECG alterations after parenteral administration (Kaul et al., 1974; 1981; 
Vick and Wiles, 1975). In spite of that, the toxin is known to induce 
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intense vasoconstriction of coronary arteries when administrated 
intravenously (Vick and Wiles, 1975; Ito et al., 1982). Thus, it is also 
possible to interpret cardiac muscle degeneration as a consequence of 
the vasoconstriction and reduced hemoperfusion induced by the toxin. 
Increase of cellular elements between skeletal myocytes and the 
presence of myoblasts on the surface of the fibers of animals treated 
with the doses of 30 and 90 µg/kg, could be related to regenerative 
processes of damaged muscle. This hypothesis would explain also why 
this kind of alteration was not visible in mice treated at the higher dose. 
In fact, it is likely that, either the damage did not had time to become so 
evident or the repair mechanisms of the body did not had time to react 
to the toxic insult. From the epidemiological data that describe the 
effects of ingestion of PLTX-contaminated seafood, appears clear that a 
damage of skeletal muscle not only may occurs, as described by 
Taniyama and co-workers (Taniyama et al., 2002), but it may also take 
several days to recover. Moreover, to support the idea that skeletal 
muscle and its regeneration may be affected by the toxin, RT-PCR 
experiments performed on embryonic and larval stages of development 
of Xenopus laevis  revealed that PLTX induced up-regulation of genes 
related to muscular development, such as myof5 (Franchini et al., 
2009).  
In the kidneys, the toxin seems to cause increase of erythrocytes 
content at all dose tested and tubular dilation at the highest dose. As 
previously described for the heart, it is possible that the renal effects 
may be due to a direct action of the toxin on the organ or to the 
vasoconstriction that can be triggered by the toxin. In literature, it is 
possible to find suggestions in this respect, because a vasoconstriction 
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particularly intense at renal level has already been reported after 
parenteral administration of the toxin (Ito et al., 1982). Ultrastructural 
alterations of the kidney in relation to the i.p. administration of the 
toxin were also described in literature, with autophagic vacuoles and 
occasional destruction of the microvilli in the proximal and distal 
tubules (Terao et al., 1992). Moreover, intra-tracheal administration of 
the toxin is known to induce glomerular atrophy already at the dose of 
1 µg/kg (Ito and Yasumoto, 2009). Reported data, on the whole, 
strongly suggest the kidneys as target organs for PLTX toxicity. 
At spleen level, decrease of lymphoid elements of lymphatic follicles 
was observed in mice treated with the two lower doses. In this respect, 
it is worth noticing that that the effects of repeated sub-lethal doses of 
PLTX on lymphoid tissues have been specifically investigated (Ito et 
al., 1997). Even if obtained after i.p. administration, this data can give 
precious suggestions for the comprehension of the alterations observed 
in our model. After 29 administrations the toxin significantly decreased 
the weight of spleen and thymus and the recovery of from this damage 
took one month to occur . Moreover, the ratio between lymphocytes 
and total leukocytes irreversibly decreased (Ito et al., 1997). On the 
whole, these data support the idea that PLTXs may have some effect at 
the level of the immune system that may represent an intriguing starting 
point for the complete comprehension of the toxic effect of this 
molecule. 
In conclusion, on the whole, from the short-term toxicity study it is 
possible to identify a LOAEL for the repeated oral administration of 30 
µg/kg. Considering the high incidence of lethality recorded during the 
study at the lower dose, this value has to be considered provisional and 
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likely to be lowered from further experiments. In spite of that, it is 
possible to propose a value of short-term reference dose (RfD) that, if 
respected, should ensure the absence of toxic effects to humans after 
short term exposure to PLTXs-contaminated seafood. In this case, to 
the commonly used safety factors (10 for the inter-species differences 
and 10 for the intra-species difference, EFSA 2009) an additional factor 
of 10 should be applied to take in consideration that a LOAEL was 
used for calculation instead of NOAEL. In this way, a RfD of 0.03 
µg/kg can be estimated. Thus, for a 60 kg person, the daily amount of 
toxin ingested within a week should not exceed 1.8 µg. This value is 
significantly lower than that proposed by EFSA for the acute reference 
dose (ARfD). If we consider the daily portion size a little smaller than 
that used for the ARfD, thus 300g instead of 400g, this means that 
concentration of PLTXs on seafood should not exceed 6 µg/kg of 
edible meat. This value is 5 times lower than that currently proposed by 
EFSA (30 µg/kg, EFSA 2009); otherwise if we consider the standard 
portion, suggested also by food consumption surveys (EFSA, 2010), 
the concentration of the toxin should not exceed 4,5 µg/kg. According 
to a recent review that summarizes the concentration of PLTX and 
analogues in seafood (Aligizaki et al., 2011) the toxin content, during 
contamination may reach considerable concentration. For instance 
PLTXs in M. galloprovincialis collected in the Adriatic sea were found 
to reach concentration up to 120-200 µg/kg  of toxin (Bellocci et al., 
2008; Aligizaki et al., 2011) and octopus up to 971 µg/kg  ovatoxin-A 
and 115 µg/kg  pPLTX (Aligizaki et al., 2011). Similarly, Ciminiello 
and co-workers reported the presence of ovatoxin-A in mussels 
between 303 and 625 µg/kg (Ciminiello et al., 2011). The consumption 
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of seafood with this level of contamination will likely results in in the 
ingestion (for adults of 60 kg b.w.) of toxins in the range of micrograms 
per kg b.w. Accordingly, EFSA panel reports that consumption of a 
large portion of shellfish harvested in contaminated areas is likely to 
result in a dietary exposure of 3 µg/kg b.w. for an adult (EFSA 2009). 
Even if this data refers to the acute consumption, they can give an idea 
of the potential exposure to the toxin and therefore rise concern about 
the more and more frequent presence of PLTX-producing organisms in 
the Mediterranean area. 
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6. CONCLUSIONS 
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In conclusion, the results obtained in vitro demonstrate the crucial role 
of  [Ca
2+
]i in determining PLTX-induced cytotoxicity also in skeletal 
muscle cells. Moreover, we show that in skeletal muscle cells, 
cytotoxicity of PLTXs is strictly related to a long-lasting and 
irreversible Ca
2+
 influx. The investigation of the mechanisms mediating 
the long-lasting phase of the Ca
2+
 influx and cytotoxicity suggests a 
prominent role for the activation of stretch-activated Ca
2+
 channels, 
possibly related to cytoskeletal disorganization and osmotic swelling 
that follow PLTX-induced ionic deregulation. The comparison of the 
effects of PLTX, 42-OH-PLTX and OST-D seems to suggest that small 
structural differences between the analogues determine considerable 
variation of biological properties. 
The investigation of the toxicity of PLTX and its analogues on primary 
culture of skeletal muscle cells gave new hints for the comprehension 
of the mechanism of action of these molecules on their target tissues 
and could contribute to the knowledge of pharmacological strategies to 
counteract their effects.  
The in vivo study revealed high toxicity of PLTX after short-term oral 
administration. Lethality after repeated administration was observed at 
doses considerably lower than those causing toxicity after single 
administration and, for this reason, these data are of crucial importance 
for the comprehension of the risk associated to the entrance of PLTX 
into the food chain and the potential threat associated to the entrance of 
contaminated seafood on the market. The definition of the short-term 
toxicity of PLTX could also help for the identification of the most 
sensitive target organ of toxicity and give precious suggestions for the 
identification/treatment of the intoxications. 
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Moreover, information for risk characterization reported in the present 
thesis will also guide toward the definition of the regulatory limits for 
the presence of PLTXs on commercialized seafood, and, as a 
consequence they also suggest the sensitivity that screening analytical 
methods should have for appropriate detection.  
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